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Figure 2-1 Figure 2-1 Microfluidic multi-zone channel for analysis of 
receptor crosstalk. a) The cell interacts with its environment 
via multiple receptor species that may generate synergistic or 
antagonist effects. Ligand binding of receptor 1 may induce 
activation of receptor 2 and expression of receptor 3 to bind 
their respective ligands. b) Schematic of the multi-zone 
channel. Cell suspension will flow in from the inlet, across four 
zones, and out from the outlet. The cells are interrogated as 
they are allowed or prevented to sequentially interact via 
different receptors with different proteins patterned on 
different zones labelled as A: pre-processing, B: stimulation, 
C: relaxation, and D: reporting. 
19 
Figure 2-2 Process of patterning four proteins on four zones without gaps. 
The procedures are shown on the left. The resulting patterns 
are shown on the right. a) Two pieces of PDMS with nearly 
matched shapes to allow the stamping PDMS (I, bottom, light 
grey) pre-coated with BSA (blue) to print BSA on the 
microchannel PDMS (II, top, light blue). b) Upon contact, 
BSA was transferred from the upper surface of the stamping 
PDMS to the bottom surface of the microchannel PDMS 
except for the area boxed by the dashed red box. c) The 
microchannel PDMS stamps on and transfers the BSA onto a 
substrate glass, forming a protein patch on the relaxation zone 
C and also blocking the areas from the inlet to zone A and from 
zone D to the outlet. d) Two protein solutions flow through two 
microchannels (arrows) to coat zones A and D. e) A flow 
chamber is assembled by placing another piece of PDMS (III, 
white) on top of the substrate glass with flow direction 
perpendicular to the protein stripes. Another protein solution 
flows in to coat zone B. 
19 
Figure 2-3 Assessment of protein coating quality. a) A three-zone device 
without zone C was coated with fibronectin (FN) in zones A 
and D and VWF-A1 in zone B. The two proteins were detected 
by their respective mAbs tagged by two different fluorophores 
and viewed by epi-fluorescence microscopy via the FITC 
(green) channel for FN (top), PE (red) channel for A1 (middle) 
or both channels (bottom). Scale bar is applicable to all images. 
b) Intensity distributions of the two fluorescent antibodies 




assessment of VWF-A1 coating. Three independent replicate 
tests were performed (indicated by different colors) using 
different devices coated with indicated concentration of VWF-
A1. Each dot indicates intensity over one 20X20 μm2 square. 
Two representative images were shown for VWF-A1 coating 
with concentration of 20 and 100 µg/ml, respectively. 
Figure 2-4 Platelet activation by VWF-A1 and ADP demonstrated by 
decreased rolling velocity on FN. Velocity of platelets rolling 
on surfaces patterned with indicated proteins is plotted vs. wall 
shear stress. Quiescent platelets (no treatment) did not interact 
with FN surface (0.016 µg/ml, coating concentration) in zone 
A (data not plotted), but rolled on VWF-A1 surface (100 
µg/ml, coating concentration) in zone B (square) and FN 
surface (0.016 µg/ml, coating concentration) in zone D 
(diamond). (This device has no zone C.) Rolling velocity on 
FN surface after VWF-A1 stimulation was significantly lower 
than on VWF-A1 surface. As a control, platelets pre-treated 
with 50 µM ADP for 15 min rolled on zone A with 
significantly lower velocity (circle). Data are presented as 
mean ± sem of 15-20 cells. Experiment was repeated 3 times 
with consistent results and the representative data are shown. 
*, ** and *** denote p < 0.05, 0.01 and 0.001 by Student t-
test. 
31 
Figure 2-5 Characterization of platelet activation and relaxation. Protein 
patterns were made to test the effects on platelet binding to 
reporting zone coated with 0.16 µg/ml FN of variable length 
of a) stimulation zone coated with 100 µg/ml A1 and b) BSA-
blocked relaxation zone. The protein patterns used in panels a 
have no zone C. Experiments were done by perfusing 1 × 108 
platelets/ml for 2 min. Each point represents measurement 
from one flow chamber. Different symbols indicate data 
obtained from different donors. Every donor donated blood 
twice for repeated experiments. *, **, *** and **** denote, p 
< 0.05, 0.01, 0.001 and 0.0001, respectively, by Student t-test. 
34 
Figure 2-6 Characterization of the effect of accumulated platelets. FN was 
coated on device with or without VWF-A1 ahead. Platelets 
adhered on surface after various time span were recorded 
without VWF-A1, and 2min with A1 stimulation was also 
plotted as a reference. No significant increase in platelet 
adhesion was observed, but all significantly lower than the A1-
stimulated condition. Each point in a and b represents 




denote, p < 0.05, 0.01, 0.001 and 0.0001, respectively, by 
Student t-test. 
Figure 2-7 Illustration of the principle of the parallel multi-zone device. 
The channel PDMS are shown on the top. The resulting 
patterns are shown on the bottom. a) The microchannel PDMS 
was previous contacted by its matching PDMS carrying 
blocking protein BSA as in Figure 2-2 a and b. Upon contact 
with glass, the rest was blocked by BSA except for the middle 
wall. That resulted a blank area (white) in the glass surface. 
Area A (green) and C (yellow) were coated by two protein 
solutions flowing through two microchannels. b) A device 
with several flow chambers was then assembled by placing 
another piece of PDMS on top of the substrate glass with flow 
direction perpendicular to the protein stripes. Protein solution 
B then be coated (red). Asymmetricity can be applied to any of 
the three area. Region A was used as an example in this 
illustration. 
37 
Figure 2-8 Assessment of the protein coating in individual flow channel. 
a) A three-zone device with only A and C coated with proteins, 
VWF-A1 and FN respectively. These two proteins were 
detected by their respective mAbs tagged by fluorophore PE 
and imaged by epifluorescence microscopy via N3 channel. b) 
The solution with fluorophore FITC was pumped in flow 
channels to visualize individual channels, by fluorescence 
microscopy via GFP channel. Dashed line indicated the edge 
of the flow channels. Slight uneven coating caused by the step 
of the protein patches was located between each channels. 
39 
Figure 3-1 Platelet adhesion on conformation specific antibodies. 
Antibodies (100 µg/ml) were coated on zones A and D to 
report the conformational change in integrin αIIbβ3 (by LIBS2) 
and upregulation of P-selectin (by AK4) on platelets after they 
were stimulated by A1 in zone B of 800 µm. The 
conformation-independent antibody HIP8 was used as positive 
control, which arrested platelets in both zones A and D. By 
comparison, platelets were able to bind LIBS2 and AK4 in 
zone D but not in zone A prior to A1 stimulation. The protein 
patterns have no zone C. Experiments were done by perfusing 
1 × 108 platelets/ml for 2 min. Data in c are presented as mean 
± quarter percentile and max/min of 6 experiments. *, **, *** 
and **** denote, p < 0.05, 0.01, 0.001 and 0.0001, 
respectively, by Student t-test. 
48 
Figure 3-2 Dose-dependent mechanical and chemical activation of 




indicated mAb zone after stimulation by the A1 zone of 
variable lengths (multi-zone channel; a) or ADP of different 
concentrations (single-zone channel; b). one-way analysis of 
variance (ANOVA) was used to assess whether the points in 
the same curve were significantly different. NS, not 
significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 
0.0001. 
Figure 3-3 Testing whole blood and comparing diabetic and healthy 
platelets. a) Platelets in whole blood from healthy donors 
respond to different lengths of VWF-A1 (100 µg/ml coating 
concentration) zone from none (BSA for zone B) up to 800 
µm. Conditions of platelets pre-activated by Mn2+ (10 μM, 15 
min) or in conventional flow chamber (a mixed of VWF-A1 
and FN) were also recorded as benchmark. b) Protein patterns 
with varied zone B (VWF-A1 stimulus) were used to compare 
platelets from diabetic and healthy donors. Platelets derived 
from diabetic donors were statistically more responsive than 
those derived from healthy donors even without stimulation (p 
< 0.05). However, much more significant differences were 
observed when washed platelets were stimulated by varied 
length of zone B coated with VWF-A1. Experiments were 
done by perfusing 1 × 108 platelets/ml for 2 min. c) 
Comparison on platelets in whole blood from both healthy and 
diabetic donors were made for both conditions of no 
stimulation and VWF-A1 (800 μm) stimulation. Diabetic 
platelets in whole blood were statistically more responsive 
even without stimulation (p < 0.01), but much more 
significantly with VWF-A1 stimulation (p < 0.0001). Each 
point in a and b represents measurement from one flow 
chamber. Different symbols indicate data obtained from 
different donors. Different symbol shapes indicate different 
donors. Empty and filled symbols distinguish healthy and 
diabetic samples. n = 4 for healthy donors, n = 2 for diabetic 
sample. *, **, *** and **** denotes p < 0.05, 0.01, 0.001 and 
0.0001, respectively, by Student t-test 
51 
Figure 3-4 Neutrophil activation. Integrin LFA-1 can be activated through 
engagement of PSFL-1 to its ligand selectin and then interact 
with integrin ligand ICAM-1. 
54 
Figure 3-5 Neutrophil activation by P-selectin demonstrated by decreased 
rolling velocity on ICAM-1. Velocity of neutrophils rolling 
patterned with indicated proteins is plotted vs. wall shear 
stress. Quiescent neutrophils (no treatment) did not interact 
with ICAM-1 surface (20 µg/ml) (data not plotted), but rolled 




surface (20 µg/ml) in after stimulation by P-selectin (blue 
triangle). Rolling velocity on ICAM-1 surface after P-selectin 
stimulation was lower than on P-selectin surface. As a control, 
platelets rolling on a surface with P-selectin and ICAM-1 co-
presented had a lower velocity (red square). Data are presented 
as mean ± sem of 15-20 cells. Experiment was repeated 3 times 
with consistent results and the representative data are shown. 
Figure 3-6 Stimulation and resulting rolling can be separated in a dose-
dependent manner to show neutrophil intermediate state. The 
activation of neutrophils was reported by their binding to 
reporting zone coated with a) ligand or b) antibodies, after 
variable length of stimulation zone coated with 20 µg/ml p-
selectin. a) ICAM-1 were coated on the reporting zone to 
report increased adhesion of LFA-1 after stimulation. 
Conventional flow chamber experiments with ICAM-1 and P-
selectin co-presented were done as a positive control, as well 
as neutrophils incubated with Mn2+ for 10min. b) Antibodies 
(100 µg/ml) were coated to report the conformational change 
in integrin LFA-1 (by Kim 127 for extension conformation, 
HI-111 for bend conformation and MEM148 for open 
conformation) on neutrophils after they were stimulated by P-
selectin. The conformation-independent antibody m25 was 
used as positive control, which arrested neutrophils in all 
stimulation lengths. By comparison, neutrophil binding 
increased to KIM127 and decreased to HI111 with increased 
stimulation dose of P-selectin. Whereas increased stimulation 
dose was not able to increase neutrophil binding to MEM148. 
Experiments were done by perfusing 2 × 106 neutrophils/ml 
for 2 min. Each point in a and b represents measurement from 
one flow chamber. *, **, *** and **** denote, p < 0.05, 0.01, 
0.001 and 0.0001, respectively, by Student t-test (a) and one-
way ANOVA (b). 
58 
Figure 3-7 Neutrophils roll on multi-zone in a stimulation dose-dependent 
manner. Velocity of neutrophils rolling on ICAM-1 (20 µg/ml) 
surfaces after variable length of stimulation zones is plotted vs. 
mechano-dose (characterized by the length of stimulation zone 
times coating concentration). Stimulation zones were 
patterned with P-selectin at various concentrations for various 
lengths Neutrophils were perfused in the chambers with a wall 
shear rate of 50 s-1. Data are presented as mean ± sem of 15-20 
cells. Experiment was repeated 3 times with consistent results 
and the representative data are shown. 
60 
Figure 3-8 Neutrophils roll on asymmetric stripes of ICAM-1. a) 




blocking surface (grey). Neutrophils were indicated in yellow 
and their anticipated trajectory in red curves. b) Neutrophils 
rolled and some adhered on the stripe surface of ICAM-1, but 
not the blocking surface. Stripes of protein pattern was 
indicated by dashed lines. c) Extracted individual trajectories 
of some representative cells. Each color indicates one 
neutrophil and each dot of that color indicates the location of 
neutrophil in one frame. 
Figure 4-1 T cell stimulation by specific pMHC. Stimulated by specific 
pMHC, T cells can be triggered with a change in integrin LFA-
1. 
65 
Figure 4-2 The observation of T cells interacting with immobilized OVA 
under flow. a) Velocity of the OT1 T cells moving on the 
pMHC surface (25 µg/ml) under a shear rate of 25 s-1. Inserted 
graph represented the number of moving T cells and adherent 
cells. Data are presented as mean ± se of 15-20 cells. 
Experiment was repeated 3 times with consistent results and 
the representative data are shown. b) Adherent cell density of 
OT1 T cells on each pMHC surface under a low shear rate of 
15 s-1. Each dot indicated one experiment. *, **, *** and **** 
denote, p < 0.05, 0.01, 0.001 and 0.0001, respectively, by 
Student t-test. 
70 
Figure 4-3 The velocity of T cells in the flow. A comparison of velocities 
above the surface (black) and near the surface (red). Velocities 
of the OT1 T cells moving above the surface, meaning no 
interaction to the surface, had no significant difference among 
the various pMHC coating. The velocity data of ‘near surface’ 
T cells were the replotted from Figure 4-3. This confirming 
that the difference of moving velocities of near surface T cells 
on various pMHC surface was not due to the flow condition. 
Data are presented as mean ± se of 15-20 cells. Experiment 
was repeated 3 times with consistent results and the 
representative data are shown. 
71 
Figure 4-4 Instantaneous velocities of T cells on surface. Cell velocities 
analyzed for 10 representative cells for each condition: a) 
adherent T cells on OVA pMHC surface, b) moving T cells on 
OVA surface and c) moving T cells on BSA surface. Each 
panel represents one cell. Videos were taken under 10x 
magnification at 36 f/s and analyzed frame by frame for 4 




Figure 4-5 Synergetic effect of TCR and integrin LFA-1 on T cell 
adhesion. Adherent cell fraction of OT1 T cells was calculated 
as ‘captured on surface / (captured on surface + collected in 
outlet)’ on each surface under a low shear rate of 25 s-1. 
Splenocyte sample includes other cell populations besides 
OT1 T cells. OVA and VSV coating concentrations were 25 
µg/ml and ICAM-1 coating concentration was 20 µg/ml. Each 
dot indicated one experiment. *, **, *** and **** denote, p < 
0.05, 0.01, 0.001 and 0.0001, respectively, by Student t-test. 
76 
Figure 4-6 Stimulation and probing activation can be separated in a dose-
dependent manner. a) Schematic of the multizone microfluidic 
channel for T cell stimulation and reporting. Highlighted 
pMHC zone is size-variable for different dose of stimulation. 
b) The activation of T cells was reported by their binding to 
reporting zone coated with ligand ICAM-1 (20 µg/ml coating 
concentration), after variable length of stimulation zone coated 
with 25 µg/ml pMHC OVA. Conventional flow chamber 
experiments with ICAM-1 and OVA co-presented were done 
as a positive control, as well as T cells incubated with Mn2+ for 
10min. Dots indicated individual experiment. *, **, *** and 
**** denotes p < 0.05, 0.01, 0.001 and 0.0001, respectively, 
by Student t-test 
77 
Figure 4-7 Activated OT1 T cell can roll on ICAM-1 in a mechano-dose- 
dependent manner. Velocity of T cells rolling on ICAM-1 (20 
µg/ml) surfaces is plotted against the length of OVA zones. 
The stimulation zones with variable lengths were patterned 
with pMHC OVA concentrations of 10 µg/ml and 25 µg/ml. T 
cells were perfused in the chambers with a wall shear rate of 
25 s-1. Negative control of T cells on ICAM-1 surface without 
pre-stimulation was plotted at dose = 0 and positive control of 
T cells incubated with PMA/ionomycin for 10 min was plotted 
at right after dash line. Data are presented as mean ± sem of 
15-20 cells. Experiment was repeated 3 times with consistent 
results. 
79 
Figure 4-8 Stimulation factors for pMHC activated T cell rolling on 
ICAM-1. a) Velocity of T cells rolling on ICAM-1 (20 µg/ml) 
surfaces is plotted vs. mechano-dose (characterized by the 
length of stimulation zone times coating concentration). The 
stimulation zones with variable lengths were patterned with 
various pMHC OVA concentrations from 5 µg/ml to 25 µg/ml. 
T cells were perfused in the chambers with a wall shear rate of 
25 s-1. Negative control of T cells on ICAM-1 surface without 
pre-stimulation was plotted at dose = 0 and positive control of 




at right after dash line. b) Rolling velocities of T cells 
stimulated by two weaker ligands were compared to OVA. 
One exponential fitting was done to collapsed OVA 
stimulation curves (black). Data are presented as mean ± sem 
of 15-20 cells. Experiment was repeated 3 times with 
consistent results. 
Figure 4-9 Calcium of pMHC-stimulated T cells indicates activation. 
Calcium flux of OT1 cells upon stimulation of pMHC a) OVA, 
b) Q4R7, c) Q4H7, d) G4, and e) VSV. BSA control (black) 
served as a reference for each condition. Data are presented as 
mean ± se of 15-20 cells. Experiment was repeated 3 times 
with consistent results. 
84 
Figure 4-10 Quantitative analysis of calcium response upon various 
pMHC. T cell calcium flux data from Figure 4-9 were analyzed 
and plotted by a) calcium peak intensity and b) area under 
curve for single cells (each dot for one cell), and c) cell 
response ratio of all collection. For binomial distribution with 
event probabilities Pk, an estimate of the i-th event probability 
was set as the associated standard error s.e.m. *, **, *** and 
**** denotes p < 0.05, 0.01, 0.001 and 0.0001, respectively, 
by Student t-test. 
86 
Figure 4-11 Anti-CD3 stimulation triggers calcium with or without shear. 
Calcium fluxes of anti-CD3 antibody 2C11 and pMHC OVA 
stimulation were compared with or without flow condition. 
Data are presented as mean ± se of 15-20 cells. Experiment 
was repeated 3 times with consistent results 
88 
Figure 5-1 T cell sorting platform. a) Scheme of the platform. It consists 
of two parts: activation zone (left) coated with target pMHC 
and sorting zone (right) coated withICAM-1. Pillar array is 
designed to increase the contact surface area in activation zone 
inclined stripes is stamped to guide the target cells to move 
laterally in the sorting zone. Two inlets: cell inlet and buffer 
inlet. Two outlets: collection outlet and discard outlet. Two 
zones can be separated. 
96 
Figure 5-2 Simulation identified the feasibility of the pillar array designs. 
a) illustration and parameters of the three designs; b) example 
of the simulation result on design #1. Red lines were 
streamline 10 µm apart. 
98 
Figure 5-3 Cell activation by calcium flux was realized in activation 
chamber. a) calcium flux of the T cells in cell traps. Data are 




times with consistent results. b) ratio of activated cells for two 
activation zone designs indicated by a calcium intensity 2x of 
the original mean intensity. Data are presented as mean ± se of 
4-5 experiments. Each dot indicates one experiment. 
Figure 5-4 Stripe inclination angles affected activated cell lateral 
movement. a) Four examples of cell trajectories for indicated 
stripes of patterned ICAM-1. Each line illustrated a single cell. 
scale bar: 10 µm. b) quantification of the trajectory angles for 
each design. 
102 
Figure 5-5 Ceiling ridge design in the sorting zone. a) cross-view 
illustration of the sorting zone. Blue stripes on the bottom 
indicated stamped ICAM-1 patterns and ridges on the ceiling 
were perpendicular to the flow direction. b) designed ridge 
parameters for difference cell sizes. 
103 
Figure 5-6 The concentration of ICAM-1 affected the lateral movement 
of target T cells. Ratio of lateral movement was depicted as 
collect/total (left). Flow left to right. Data are presented as 
mean ± se of 3 experiments. *, ** and *** denote p < 0.05, 
0.01 and 0.001 by Student t-test. 
104 
Figure 5-7 Stop-flow pattern allow better lateral movement. a) mean 
velocity of 5 cells in a flow-stop condition. Flow stopped at t 
= 10s. b) illustration of ratio of the two side, for an even 
distribution of cells, ratio = 1 at the beginning. c) ratio of two 
side plotted for five stop-flow patterns listed on the bottom. 
Exact numbers of ratios were listed in the table below the 
graph. 
106 
Figure 5-8 Lateral movement of the stimulated cells and non-stimulated 
cells. a) illustration of the ratio of lateral movement as 
collect/total. Flow left to right. b) lateral movement of the 
stimulated and non-stimulated OT1 T cells. Data are presented 
as mean ± se of 3 experiments. *, ** and *** denote p < 0.05, 
0.01 and 0.001 by Student t-test. 
107 
Figure 5-9 Primary OT1 T cells sorted from a mixture with non-target B6 
T cells. a) illustration of the lateral movement and ratio of 
sorted cells for each population. b) Sorting performance of 
OT1 and B6 in a mixture on two separate days. Data are 
presented as mean ± se of 2-3 experiments. Experiment was 
repeated 3 times with consistent results. 
109 
Figure 5-10 Distinguish OVA (strong ligand) stimulated and G4 (weak 




OT1 T cells from same batch was activated in two activation 
chambers. b) The mixture of the two populations in sorting 
region. c) The ratio of potentially sorted cells for two 
populations along the channel. Data are presented as mean ± 
se of 2-3 experiments. 
Figure 5-11 Assessment of the distinguishing capability by two 
populations stimulated by two pMHCs with close potency. The 
ratio of potentially sorted cells for two populations along the 
channel. Data are presented as mean ± se of 2-3 experiments. 
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A 1 A 1. Process to align markers on channel device to the zone 
location. Stamp and contacted substrate glass were placed and 
taped onto a mask with markers. Took off the stamp before put 
channel device onto the glass according to the markers on the 
mask. Held the device and delivered coating solution with the 
clamp. 
120 
A 2 A 2. Activation maturation of platelets on reporting zone. 
Individual platelet velocities on Fg (a) or FN (b) were plotted 
after activation by VWF-A1. c) A summary of the velocities 
was plotted, and velocities were compared across the time of 
platelets on reporting zone. Dots indicated individual 
experiment. *, **, *** and **** denotes p < 0.05, 0.01, 0.001 
and 0.0001, respectively, by One-way ANOVA. 
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A 3 A 3. Existence of the antibody KIM127 by gel electrophoresis. 
Three difference concentrated media supernatant was 
compared to the calibration. Left was the original supernatant, 
protein detected at ~150KD (supposed to be the antibody 
KIM127). right was reduced (break the disulfide), heavy chain 
and light chain can be observed. 
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A 4 A 4. Extraction and purification of antibody KIM127. Protein 
was shown to exist in original supernatant and elution solution, 
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 Cells use their surface receptors to anchor to and communicate with other cells and 
the extracellular matrix. Such processes usually involve interactions of multiple receptor-
ligand pairs occurring independently, cooperatively, or antagonistically. The study of 
crosstalk among different receptor species can be benefitted by techniques that are efficient, 
high throughput, and easy to use. Conventional approaches have difficulties to control each 
ligand precisely or detangle measurement of cell adhesion by each receptor-ligand pair. 
This thesis describes the development of two platforms to address this deficiency and their 
applications to several problems in cellular engineering. 
The first platform of an auto-alignment protein patterning approach enables a 
sequential ligand presentation. This allows moving cells to interact with spatially separated 
ligands sequentially, thus dissecting the crosstalk between different receptors by detangling 
temporally their ligand interactions and reporting the effect of triggering one receptor by 
the altered binding of another receptor. This device with multiple zones of ligand coating 
allows precise and tunable control over the species, the density and the zone length of 
surface-immobilized molecules. A parallel version of this device permits controls over 
various stimulations on the same chip and further improved the throughput. 
This multi-zone system is first applied to provide independent evidence for the 
presence of an intermediate state of the major integrins on platelets and leukocytes. An 
intermediate state of integrin αIIbβ3 was demonstrated by triggering GPIb with VWF-A1 
immobilized on one zone and measuring platelet adhesion to fibronectin or conformation 
reporter antibodies coated on another zone. Furthermore, the increased binding of integrin 
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αIIbβ3 upregulated by VWF-A1 was found in diabetic platelets. The assay required only 
one-drop of blood, thus potentially applicable for diabetic state monitoring upon further 
development. The intermediate state of integrin αLβ2 (LFA-1) was similarly studied. On 
human neutrophils, this intermediate state LFA-1 was upregulated by P-selectin-ligand and 
reported by conformation reporter antibodies. On mouse T lymphocytes, the intermediate 
state LFA-1 was upregulated by TCR-pMHC and reported by rolling adhesion on ICAM-
1 and by intracellular calcium fluxes. The effects of “dose” were revealed through precise 
control of the length and ligand density of the stimulus zone and the perfusion flowrate. 
The second system is to sort antigen-specific T cells based on TCR triggering 
studied earlier using the multi-zone device. The effective interaction of TCR-pMHC can 
lead to an activation of LFA-1, whose differential ICAM-1 binding amplifies the difference 
in pMHC binding to T cells with different T cell receptor clones. The sorting chip first 
triggers T cells by specific pMHC and then allows activated T cells to move laterally on a 
patterned ICAM-1 surface to separate cells with activated LFA-1 supported rolling. The 
platform was validated by two experiments: 1) sorting T cells from OT1 TCR transgenic 
mice specific for OVA pMHC from non-specific T cells from B6 mice, 2) characterizing 
OT1 T cell rolling on ICAM-1 and calcium fluxes in response to triggering by pMHCs of 
various biological activities. Considering its advantages including short time scale, 
continuous sorting manner, and module compatibility, this platform can potentially be 
implemented for enumeration and isolation of functional T cells. 
Overall, this thesis developed an approach for studying cell multi-receptor crosstalk 
generalizable to various receptor mechanobiology and applied to mechanistic studies to 
potential clinical applications, revealing the advantages of microfluidics in disease studies 
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and diagnostics. In addition, the platform for functional antigen-specific T cell sorting 






CHAPTER 1. INTRODUCTION 
 
1.1 Cell adhesion and multi-protein engagement in cell function 
1.1.1 Cell adhesion 
 Cell adhesion is formed by the direct physical binding of the receptor molecules 
anchored on the cell surface and the ligand molecules on another cell surface or on the 
extracellular matrix (ECM). This adhesive binding is an important means of cells for 
communication with the environment, and affects various cell functions including 
navigation, proliferation, differentiation, survival and more [1, 2]. Physiological processes 
largely involve adequate cell adhesion by receptor-ligand interactions, such as wound 
healing and immune cell recruitment, while abnormity of cell adhesions is often associated 
with pathological conditions, such as thrombosis, cancer metastasis and autoimmunity. 
Thus, understanding the properties of cell adhesion holds a great value in pathology, 
clinical practice, and bioengineering device development. 
 Corresponding to different cell functions, cell adhesions tend to exhibit different 
behaviors, which can be used to evaluate the function and dysfunction of cell adhesion. For 
instance, firm arrest is one of the common cell adhesive behaviors, and so is continuous 
slow rolling [3].  
 When cell adhesion is measured at the cellular level, the cell adhesion strength is 
determined by the magnitude of the exerted force and the avidity by the likelihood of cells 
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adhering or departure which can be measured via techniques such as micropillar [4] and 
DNA force probe [5]. Rolling velocity of translocating cells is another measurement for 
fast association and fast dissociation interactions. Flow chamber is one way to measure the 
rolling velocity [3]. In addition, more measuring assays can be employed to assess other 
aspects of cell adhesion. Cell adhesion can also be quantified at molecular level, which 
requires the measurement of kinetic parameters, such as the association (Kon) and 
dissociation (Koff) rate, affinity (Ka), and lifetime under force, by dynamic force 
spectroscopy technologies [6].  
1.1.2 Cell adhesion involving multi-protein engagement 
 The complicated and variable cell interactive functions are not easily achievable 
from single type of receptor-ligand binding. Instead, interactions of multiple receptor-
ligand species are usually concurrently involved to fulfil cell adhesion functions [7].  
 In some cases, these interactions are independent, whereas in a lot of other cases, 
interactions are cooperative and causally related. For instance, cooperative binding induced 
platelet adhesion and activation occurs at vascular injury sites. In order to attach onto the 
exposed sub-endothelium, platelets first use glycoprotein (GP) Ib to translocate on the 
endothelial cell surface-immobilized von Willebrand factor (VWF) via its A1 domain 
(VWF-A1). This binding activates GPIIb-IIIa (integrin αIIbβ3) via mechano-signaling, and 
in turn enables GPIIb-IIIa to mediate platlet firm adhesion [8-10]. Such a sequential 
process enables efficient platelet recruitment during hemostatic and thrombotic processes, 
and also induces P-selectin expression [11] that is potentially important to other functions 
of platelets, e.g., in immune responses [12, 13]. Another example of cooperative interaction 
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laid in neutrophil recruitment to inflamed tissue, which is initiated by the engagement of 
selectins and followed by integrin-mediated rolling and firm arrest [14]. In addition, the 
adaptive immune response mediated by T lymphocyte cells also benefit from the 
cooperative receptor-ligand interactions. T cell receptor (TCR) on T cell surface states the 
recognition of peptide-loaded major histocompatibility complex (pMHC) on an antigen 
presenting cell (APC), which activates αLβ2 (LFA-1, CD11a/CD18) to establish concurrent 
binding with the APC surface ICAM-1 so as to stabilize the T cell-APC contact [2]. In 
some other systems, antagonistic effects are also observed between different receptors, 
with the function of one receptor suppressed by the ligand-binding of another. In many 
biological contexts, the exact nature of these interactions is largely unknown. 
 While the study of a single pair of receptor-ligand can enlarge our understanding 
of cell adhesion, a systematic study of multi-protein engagement in cellular processes is of 
essence to the understanding cell functions in a more comprehensive way, potentially 
allowing target therapy for suppression of cell abnormity functions bur retaining other 
functions. 
1.2 Conventional tools to study surface protein adhesion kinetics 
 Cell adhesion to a surface consists of an initial binding and a firm attachment 
followed by spreading, morphological changes, migration or aggregation. Receptor-ligand 
binding mediates the initial cell adhesion and its kinetics have been widely studied by 
assays such as surface plasma resonance (SPR) by measuring surface immobilized 
molecules to another molecules in solution. However, cell adhesion via receptor-ligand 
occurs between cell surface molecules and molecules anchored on another surface (ECM 
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or other cells), known as 2D kinetics [15-17] whereas kinetics by assays such as SPR is 
known as 3D interaction kinetics. 3D assays may be insufficient in describing physiological 
cell adhesion because surface molecules can be clustered or linked to other molecules under 
physiological conditions, which may affect their binding abilities. In these cases, 2D 
kinetics may be more physiologically relevant [16]. Hence studies of receptor-ligand 
interactions between surface anchored molecules is more provocative rather molecules in 
a solution. 2D interaction kinetics can be measured by assays including AFM [18], optical 
tweezer [19], micropipette adhesion assay [17], and flow chamber [20, 21].  
 Flow chamber devices have been widely used as in vitro models to assess cell 
behavior exposed to dynamic fluid flow in a more natural, physiological environment [22-
25]. A flow chamber typically consists of three parts: a polycarbonate distributor, a silicon 
gasket, and a glass coverslip. The coverslip can be coated with proteins, cells, or 
biomaterials of interest. Flow chamber studies can mimic the physiological condition and 
investigate hundreds of cells, yet contacts between cell and protein is loosely controlled, 
making it hard to investigate stimulus in right amount of time and interpret adhesion 
kinetics directly [3]. 
 Micropipette adhesion assay utilize a human red blood cell (RBC) as a force 
transducer to detect adhesion events where RBC’s low spring constant makes it an 
excellent candidate for sensing small forces (10-110pN) [26]. The RBC is coated with 
ligand of interest via covalent linking and aspirated on a micropipette connected to a piezo-
driven micromanipulator [17]. On the other side is a target cell bearing the receptor of 
interest. The two cells are brought into repeated contact and separation at defined contact 
durations for tens to hundreds of times. The dependence of adhesion frequency on contact 
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duration enables kinetic rates to be determined from a probabilistic model at constant 
ligand and receptor densities, and constant contact area between the cells [15]. This 
probabilistic model (Equation 1) is based on the analysis of kinetics for systems which 
assumes a small number of bonds are formed during the adhesion events [26] and that the 
adhesion events are infrequent and follow a Poisson distribution [15]. Despite of the force 
sensitivity (10pN) and direct interpretation of adhesion kinetics from micropipette 
adhesion assay, only one cell can be interrogated at a time, making this a laborious, low 
throughput technique. 
𝑷 = 𝟏 − 𝒆−𝒎𝒓𝒎𝒍𝑨𝒓𝑲𝒂[𝟏−𝒆
−𝒌𝒐𝒇𝒇𝒕⁡]⁡ 
Equation 1[17] 
 Cell adhesion can be measured in similar principles of single cell approach using 
techniques such as atomic force microscopy (AFM) [18], biomembrane force probe (BFP) 
[27], and optical tweezers (OT) [19]. However, these 2D kinetics assays for single cell, 
single molecular measurements also suffer from the low throughput and high experience 
requirement. 
1.3 Microfluidic systems for probing cell adhesion 
 As an emerging cell manipulation technique, microfluidics has been developed for 
cell adhesion and brings the benefits of precise environmental control, convenience in cell-
size feature fabrication and simple operation. Microfluidics can probe cell adhesion in both 
initial adhering processes and later firm adhesion (including spreading, aggregation, 
migration and deformations) [28].  
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 With the precise control of the environment - and in particular fluid shear - 
microfluidic approaches to study cell adhesion can be categorized in three groups: 
attachment assays, detachment assays and rolling assays. 
1. Attachment assays. Microfluidic surfaces or other structural features can be 
functionalized by adhesive molecules to examine cell adhesion under 
certain shear force. As an example, Murphy and co-workers [29, 30] 
employed a device with a linear shear stress specific peptide and 
demonstrated the dependency of the adhesion of endothelial cells (ECs) and 
smooth muscle cells (SMCs) on peptides and shear stress by measuring the 
adhered cell number. Attachment assays reflect shear dependence of the cell 
on rate to the adhesive surfaces. 
2. Detachment assays. Compared to other micromanipulation assays to detach 
an adhered cell, microfluidics is noninvasive and so overcomes the risk of 
cell damage by applying a range of shear for detachment. Surface conditions, 
fluid shear, and the chemical environment can all be well-controlled in 
microfluidics. As an example, fibroblast adhesion strength to the fibronectin 
(FN)-coated substrate was demonstrated as a function of surface coating 
concentration and shear stress by Lu et al [31]. Human papillomavirus 
(HPV)-infected cells were also assessed using this detachment assay by 
Wankhede et al. [32]. Detachment assays reflect the cell off-rate to the 
adhesive surfaces.  
3. Rolling assay. Cell rolling is a specific cell behavior enabled by rapid on-
rate and off-rate of the cell adhesion and so reveals an important mechanism 
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of cells interacting specific cellular cues. This behavior is prevalent in 
physiological processes such as neutrophil recruitment to inflammation 
sites, stem cells homing to bone marrow niches, and platelets adhering to 
injury sites. Simone et al. [33] examined the tumor cell behavior from firm 
adhesion and adhesive rolling for the shear regime in a microfluidic device.  
 Cell spreading and force measurement have also been investigated in microfluidics 
by employing the existing techniques of imaging cell morphology [4] and traction force 
measurements [4, 5].  
 
1.4 Biological application: Platelet activation and hyperactivity in diabetes 
1.4.1 Platelet activation via mechano-signaling of GPIb 
 Platelet plays a primary role in haemostasis, namely to stop bleeding and preserve 
tissue when a vascular injury happens. Vascular injury sites recruit circulating platelets in 
blood stream which leads to a cascade of events including platelet adhesion, activation and 
aggregation. Eventually, a blood clot (thrombus) formed by platelets obstructs the flow of 
bleeding and allows tissue repairment. A similar process also happens in the pathological 
conditions, known as severe thrombosis, one of the most fatal diseases where the ultra-
large thrombus blocks the entire blood vessel which can cause ischemia in the heart and 
brain. Understanding platelet adhesion and activation in physiological and pathological 
conditions builds the foundation to drug discovery for preventing severe thrombosis 
without having excessive bleeding as a side effect. 
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 Early adhesion and aggregation of platelets involve the binding of multiple 
receptor-ligand pairs. Under high shear flow conditions (> 800 s-1) which exists in most 
arties and pathological conditions, the adhesion and recruitment of platelets on endothelia 
is usually initiated by the binding of platelet transmembrane molecule glycoprotein (GP) 
Ib to surface-immobilized von Willebrand factor (VWF) A1 domain (VWF-A1). This 
binding, under flow condition, then activates GPIIb-IIIa (integrin αIIbβ3), which provokes 
further binding and self-activation. Both the initial binding of GPIb to VWF-A1 and the 
activation are dependent on the highly shear force [34]. Therefore, the shear forces are 
substantial for the study of the multiple receptor-ligand interactions and the crosstalk of 
these surface proteins. 
1.4.2 Integrin activation and conformational changes 
 Integrins are a group of transmembrane proteins widely existing on cell surface, 
and one of the major adhesive receptor families among other three (cadherin, selectin and 
immunoglobulin-superfamily) [35]. Integrin plays an important role in cell interaction to 
extracellular matrix (ECM) [35, 36] and hetero-species cells [35, 37], and thus facilitate 
the navigation, communication and homing of cells to the environment. Each integrin is a 
heterodimer composed of two components: an α subunit (18 species known in mammalian 
cells) and a β subunit (8 species known), which in combination create a total of 24 kinds 
of integrins [38]. Among the several integrins expressed on platelet surface, αIIbβ3 is the 




 Integrin αIIbβ3 is a receptor to a set of ligands: fibrinogen (Fg), von Willebrand 
factor (VWF), fibronectin (FN) and vitronectin. As a signature attribute, the binding 
capacity of αIIbβ3 highly depends on its activation state. While residing on the platelet 
surface with an equilibrium between inactive and active states, integrin αIIbβ3 on the 
quiescent and discoid-shape platelet are mainly inactive, with a low affinity to its ligands. 
Upon activation, the change of its conformation (separation of αIIb and β3 tail by inside-out 
signaling, and hybrid-domain swing-out by further activation signaling) permits a high 
affinity to ligands, which leads to platelet arrest and aggregation [9, 39]. Although the 
existence of different integrin conformations was largely revealed in literature, how they 
correspond to the different affinity states upon various activation signals remained unclear. 
1.4.3 Diabetic platelets are hyperactive 
 Diabetic patients have an increased risk of atherothrombosis; in these patients, 
platelets are hyper-reactive, meaning that they are more responsive to stimulation, form 
aggregates more readily, and adhere more efficiently on thrombogenic surfaces [40, 41]. 
As a result, up to 80% of deaths from diabetes are related to atherothrombosis [42]. 
Diabetic platelets are also less responsive to the standard antiplatelet therapy, such as 
aspirin and clopidogrel, whereas more potent antithrombotic therapy would increase the 
risk of serious bleeding, potentially nullifying the clinical benefits of this approach [43]. 
The diagnostic of thrombotic risks in diabetic patients, especially at an early stage, is thus 
critical. Interestingly, despite the hyperactive status, diabetic platelets remain discoid 
which normally corresponds to a quiescent state of healthy platelets. There lacks a sensitive 
assay to determine the thrombosis risk of early stage of patients clinically in an easy-
accessible monitoring manner. 
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1.5 Biological application: T cell antigen-specific activation 
1.5.1 T cell immune function with antigen-specificity 
 T cells play a critical role in adaptive immunity to recognize foreign pathogens and 
exert an immune response. The recognition of antigens and activation of T cells start with 
the binding of the T cell receptor (TCR) to an antigenic peptide fragment bound to a major 
histocompatibility complex (pMHC) on an antigen presenting cell (APC) [44, 45]. T cell 
receptors by alternation of receptor gene segments have a broad repertoire covering more 
than a million of unique biological structures. T cells can recognize foreign antigens with 
high sensitivity, specificity and speed, while maintaining tolerance to self-antigens that are 
more abundant in the environment. Albeit the difference between foreign antigen and self-
antigen could be only a few amino acids, recent studies have shown that cell activation can 
triggered by the binding to a few antigenic pMHCs or even a single pMHC while 
discriminating from outnumbered endogenous pMHCs. Any abnormity in recognizing 
foreign antigens or tolerating self-antigens leads to immune deficiency [46] or autoimmune 
diseases [47]. The binding to specific antigen and subsequent triggering of activation can 
cause responses including chemokine release, cytotoxicity and proliferation. Therefore, it 
holds a great interest to study the underlying mechanism of T cell activation via TCR-
pMHC interaction. 
  
1.5.2 Conditions required for T cell activation via antigen-specific TCR 
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 Despite the profound study in T cell activation, the mechanism of the very initial 
triggering through antigen specific TCR is yet elusive. Various triggering models have 
been proposed to describe the required T cell activation conditions [44, 45, 48].  
1. Receptor occupancy model is a very early model that emphases the TCR 
binding affinity to antigenic pMHC [49]. This model suggests that during 
interaction, more T cell receptor occupied owing to the high binding affinity 
of the antigenic pMHC. Only pMHCs that have high affinity could give rise 
to a high TCR occupancy that triggers the T cell activation. 
2. The kinetic proofreading model gained popularity in explaining the T cell 
sensitivity and specificity in discriminating antigenic and endogenous 
pMHCs. First adapted from DNA replication models [50], this model was 
then developed and modified by many groups [51-54]. The main theory is 
that T cell events start to happen upon a binding; only when sufficient events 
happen before dissociation, a T cell activates. Therefore, sufficient long 
TCR-pMHC binding lifetime is required for T cell activation. 
3. Serial triggering model extends the kinetic proofreading model, explaining 
how pMHC with relatively short dwell time can also cause T cell activation 
[55]. This model proposed by Valitutti et al. [56] posits that a single 
antigenic pMHC can serially trigger many TCRs. 
4. Mechano-sensor model consider TCR as a mechanosensor that mediates 
conformational changes. The force associated with the TCR-pMHC binding 
was suggested to cause conformational changes in TCR chains [57]. Recent 
studies by Liu et al. [58] suggested that a moderate amount of force sustains 
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TCR binding to antigenic pMHC but reduces the lifetime to non-stimulatory 
ligands. 
5. Kinetic segregation model focuses more on the signal propagation process 
[59]. It posits that TCR-pMHC interaction (complex < 15 nm) creates a 
small membrane gap between T cell and APC, which excludes relatively 
big molecules like CD45. CD45 exclusion then triggers Lck activity and 
TCR phosphorylation. 
 Though various models are hypothesized, they are not necessarily mutual exclusive. 
More technological approach development allows more observant evidence to help 
understand this complex process. 
1.5.3 Integrin activation and immune synapse 
 T cell activation gives rise to a serial response, including an immediate intracellular 
protein phosphorylation, a rapid calcium flux, surface marker activation, cytokine 
production, and differentiation or proliferation. Among these, surface integrin activation is 
critical in T cell subsequent functions, and failure leads to fatal consequences such as 
leukocyte adhesion deficiency (LAD) disorders [60]. Lymphocyte function-associated 
antigen 1 (LFA-1, also named αLβ2 for its two subunits) is the predominant integrin on T 
cell surface, whose functions include but are not limited to T cell trafficking on endothelial 
cells, homing to lymph nodes, and stabilizing T cell-APC contact [61]. 
 One of the major functions of LFA-1 is to stabilize the contact of T cell and APC 
at the immune synapse [62]. The immunological synapse (IS), formed during TCR antigen 
recognition, is a stable region of contact initiated by TCR and pMHC but held together by 
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LFA-1 on T cell and ICAM-1 on APC [63]. The mature IS consists two parts: a cluster of 
T cell receptors in the center and a surrounding ring that incorporates LFA-1 [63, 64].  
 LFA-1 activation on T cells can be triggered by chemokine signaling, TCR specific 
interaction, and selectin binding, which consists of conformation changes of the integrin 
from bent, resting form all the way to an extended, open form [38, 65]. The same molecule 
expressed on neutrophil surface has been extensively studied to have a low affinity state, 
an intermediate state and a fully activated state [14, 66, 67]. However, whether the LFA-1 
on lymphocyte surface shares the same sets of affinity states remains unclear. 
 
1.6 Microfluidic surface functionalization techniques 
 Protein micropatterning (surface functionalization), the process to place target 
proteins/chemicals at well-defined locations, has a tremendous value in biological studies 
such as cellular adhesion [68, 69], and for certain biological assays such as combinatorial 
screening [70], drug discovery [71] and cell sorting [72, 73]. A variety of biomolecule 
micropatterning techniques have been developed over the past few decades and some 
typical approaches are introduced in this section. 
1.6.1 Microcontact printing 
 Microcontact printing (µCP), namely stamping, is the most common patterning 
technique. It was first introduced by Whitesides and his coworkers for fast replication of 
patterns generated by photolithography [74, 75], and it has advanced significantly since its 
invention. µCP uses a polydimethylsiloxane (PDMS) stamp to transfer biomolecules of 
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interest to a target surface. Advanced lithography techniques can be used to make PDMS 
stamps with complex features and therefore allow µCP to generate patterns with complex 
geometries. In addition, the proper choice of materials and surface treatment methods allow 
sub-micron size features. However, the limitations reside when dealing with the patterns 
involving multiple protein species. Each stamp only carries one type of protein ink so 
alignment of several stamps to achieve a multi-protein pattern is required. Alignment is 
usually undesirable for two or more stamps, much bigger than feature size which is 
comparable with cell sizes. 
1.6.2 Microchannel patterning 
 Besides surface transfer, protein in solution could deposit or be absorb to a desired 
surface during incubation and that solution can be guided on certain location of a surface 
by fluid channels. Microchannel patterning (coating in capillaries) was developed for the 
patterning of multiple biological cues [76]. PDMS featured with multiple microchannels is 
used to make contact with a substrate surface. Separated channels guide biomolecular 
solution to the desired regions on a substrate, thereby achieving auto-alignment in terms of 
the relative location of these molecule patterns. However, the location of the proteins has 
its constraints due to the channel walls that separate the microchannels, which is relatively 
large compared to the size of a cell. Direct adjacency of proteins of the interest is then not 
achievable and big gaps exist between protein patterns, unwanted in some applications. 
1.6.3 Laminar flow patterning 
 The distinctive property of laminar flow in microfluidics enables another 
micropatterning approach: laminar flow patterning [77]. A Stokes flow, namely creeping 
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flow, is a type of laminar flow when the inertial term is negligible compared to the viscous 
term. With a very low Reynolds number (inertial force/ viscous force < 1), mixing of two 
solutions can hardly happen in Stokes flow. Using this distinctive property, two or multiple 
streams of fluid can flow next to each other without lateral mixing except for diffusion or 
potential chemical reaction. This phenomenon was then used in micropatterning to create 
no-gap protein patterns. Position of the patterns is therefore more flexible, not restricted by 
any channel wall between two type of proteins. This is a feasible approach for the 
patterning proteins that require a short-term incubation on a surface. However, many 
biomolecules require long-term incubation periods in order to pattern, and in these cases, 
using laminar flow patterning can result in a middle area contaminated by two neighboring 
proteins that is much larger than a cell size.  
 
1.7 Thesis outline 
 This thesis presents new sets of platforms for multi-receptor crosstalk study on cell 
surface and for specific cell sorting based on the adhesion signature resulting from crosstalk. 
Microfluidics in this study enables the manipulation of small volume of liquids and small 
particles like blood cells, the creation of the microstructures for the desirable feature shapes 
and locations, the module-compatibility for different cell functions to take place. We 
attained the phenomena of multi-receptor crosstalk in several acclaimed species of blood 
cells, assessed the activation behavior and requirement in a fine-tuned well-defined manner, 
achieved cell of interest distinguishing. 
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 CHAPTER 2 (Microfluidic auto-alignment of protein patterns for sequential 
ligand presentation) presents a new approach that permits cell surface receptor crosstalk 
by an auto-alignment of multi-protein patterning for sequential ligand presentation to cells. 
With well controlled spatial registration and protein density, this system can provide 
tunable mechano-stimulation dose to study cell multi-receptor adhesion and signaling 
cascades. Validation of the device by assessing platelet adhesion and activation revealed 
the threshold, saturation and reversibility of the platelet activation by immobilized ligands 
in drop of blood, which is not achievable by gold standard approaches. Further 
development of a parallel device based on the initial version enables better variation control 
and throughput. 
 CHAPTER 3 (Cell activation and receptor crosstalk on multi-zone device) 
presents the wide application of the multi-zone device (in CHAPTER 2) in the discovery 
of the activation states and the differentiation of subtle pathological conditions. In this 
chapter, we characterized the activation parameters, behaviors and molecular changes of 
platelets and neutrophils upon stimulation to reveal an intermediate state of the integrins 
on both cells upon activation. We successfully assessed one-drop of whole blood sample 
and detected the subtle differences in diabetic platelets with an amplification upon 
activation, which is hard to notice in other ways with such limited sample. 
 CHAPTER 4 (TCR-pMHC interaction under flow induces intermediate-
affinity of LFA-1 to support rolling adhesion) presents the discovery of the T cell 
activation condition under shear flow condition and an intermediate state of integrin using 
the platform developed in CHAPTER 2. In this chapter, we demonstrated that T cells can 
be activation by rapid rebinding of TCR-pMHC interaction under flow, and that leads to 
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an integrin activation state supporting T cell rolling on ICAM surface. Mechanical 
stimulation dose of immobilized pMHC was fine controlled for the study of dose-
dependent, pMHC-dependent rolling behavior. Calcium flux of T cells upon activation was 
also investigated. 
 CHAPTER 5 (Engineer microfluidic platform to sort antigen-specific T cells 
based on rolling behavior resulting from TCR-integrin crosstalk) employed the 
discovery of integrin LFA-1 lateral movement from CHAPTER 3 and the rolling property 
of T cells in various activation conditions from CHAPTER 4 to sort antigen-specific T 
cells. In this chapter, we developed a cell sorting platform that enables target T cells upon 
activation to move laterally by cell adhesion so to distinguish from non-interactive cells. 
This platform was validated by mouse primary OT1 T cell sorting from non-target cells 
and also implied the capability of spectrum sorting of multiple interactive cell types with 




CHAPTER 2. MICROFLUIDIC AUTO-ALIGNMENT OF 
PROTEIN PATTERNS FOR SEQUENTIAL LIGAND 
PRESENTATION 
Part of the work presented in this chapter has been published in Lab on a Chip1. 
  Cell adhesion plays a critical role in many cellular functions such as the 
hemostatic/thrombotic process, inflammatory reaction, and adaptive immune response. 
Many cell adhesion processes involve cross-talks between multiple ligand–receptor 
systems through intracellular signaling. To elucidate such crosstalk requires analysis of the 
synergistic or antagonistic effects of binding and signaling of multi-receptor species. 
Current techniques for such analysis are either labor-intensive, low-throughput, or limited 
in the types of ligands they can interrogate. To circumvent these limitations requires a 
technique for manipulating the ligand interaction with and measuring the functional 
response of a population of cells. We have developed a microfluidic platform for studying 
binding and signaling of multi-receptor species by separating their actions in space and 
time. The platform directs cells through a single channel and uses sequentially presented 
ligands for pre-processing and stimulating cells, followed by reporting of cell activation 
states and functional consequences. Our method sequentially patterns proteins on different 
spatial regions without gaps. We demonstrated the ultility of our method by using this 
platform to analyze the crosstalk between platelet receptors, glycoprotein Ib and IIb-IIIa, 
in the context of platelet adhesion and signaling under flow 
 
1 Zhou, F., et al. (2018). "Microfluidic auto-alignment of protein patterns for dissecting 




 Specific interactions of a cell with another cell or with the extracellular matrix via 
direct physical contact usually involves multiple receptor–ligand interactions [7]. In some 
cases, these interactions are concurrent and independent, whereas in other cases, the 
interactions are sequential and cooperative. An example of the former case is binding of 
two neutrophil receptors (FcγRIIA and FcγRIIIB) to a common ligand mix (total IgG), 
which can be treated as concurrent and independent when the bond numbers are low 
enough for competition to be neglected [78]. Concurrent and independent interactions 
result in a total bond number that is equal to the sum of two bond species [78]. As an 
example of sequential and cooperative binding, moving platelets use glycoprotein (GP) Ib 
to transiently bind surface-immobilized von Willebrand factor (VWF) A1 domain (VWF-
A1), which activates GPIIb-IIIa (integrin αIIbβ3) via mechano-signaling. The sequential 
process enables efficient platelet adhesion during hemostatic and thrombotic processes [9], 
and also induces P-selectin expression [11] (Figure 2-1 a). In some other systems, the 
binding of a receptor can also trigger suppression of the function of another receptor [79]. 
In many biological contexts, the exact nature of these interactions is largely unknown.  
 
Figure 2-1 Microfluidic multi-zone channel for analysis of receptor crosstalk. a) 
The cell interacts with its environment via multiple receptor species that may 
generate synergistic or antagonist effects. Ligand binding of receptor 1 may 
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induce activation of receptor 2 and expression of receptor 3 to bind their 
respective ligands. b) Schematic of the multi-zone channel. Cell suspension will 
flow in from the inlet, across four zones, and out from the outlet. The cells are 
interrogated as they are allowed or prevented to sequentially interact via 
different receptors with different proteins patterned on different zones labelled 
as A: pre-processing, B: stimulation, C: relaxation, and D: reporting. 
 To analyze these synergistic or antagonistic effects among multi-species receptor–
ligand interactions requires temporal and spatial control of when and where each receptor 
species can interact with their respective ligand or reporting antibody, in what sequence, 
and for how long. A recent study employed a newly developed dual biomembrane force 
probe to achieve this goal [80]. The study analyzed the crosstalk of GPIb with αIIbβ3 (and 
P-selectin) by allowing the two receptors to sequentially encounter their respective ligand 
(or antibody) in space and time, so as to monitor the activity change of αIIbβ3 (and surface 
expression of P-selectin) as a consequence of GPIb signaling. While extremely well-
controlled and sensitive, this method is limited in that it requires manually moving a single 
cell to contact two ligand-bearing surfaces [80] and do so alternatingly; these actions are 
technically challenging, and of low temporal resolution and low throughput. In addition, 
this technique cannot recapitulate the flow condition physiological for certain cell types. 
We hypothesize that these limitations can be overcome with the use of well-engineered 
microfluidic devices that use flow to deliver cells into contact with a series of protein 
patterns with spatiotemporal control.  
 In the literature, a variety of protein micropatterning techniques have been 
developed, which include microcontact printing [74, 75], microchannel [76], and laminar 
flow coating [77]. Microcontact printing is the most common patterning technique. It uses 
the relief patterns on a stamp surface to print protein patterns on the substrate. While this 
technique can generate patterns of complex geometry, alignment of two or more stamps is 
technically difficult and thus lacks accuracy and uniformity [81]. Microchannels have also 
been used to generate protein patterns. Separate channels guide different protein solutions 
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to their desired regions on a substrate, thereby achieving automatic alignment. However, 
walls separating the microchannels are relatively large compared to the cell size, resulting 
in undesirable large gaps between patterns. Another patterning technique, laminar flow 
patterning [77], utilizes the non-mixing property of Stokes flow to create patterns. It allows 
two or more layers of fluid to flow next to each other without lateral mixing except for 
diffusion or potential reaction. Yet, diffusion could occur and is hard to control, potentially 
resulting in protein contamination regions much larger than the cells [82]. 
 To study crosstalk between two cell-surface receptor species, an ideal microfluidic 
device system should automatically present the stimuli followed by an immediate readout 
of the cell status (Figure 2-1 b). Specifically, upon entering the device, the cells would first 
be stimulated by a protein patch with a precise dosage (concentration and time) to trigger 
the desired level of activation, and then be interrogated by a protein patch to report any 
changes in the expression, conformation, or activity of the other receptor species. Other 
important features include pre-screening of the cells to ensure they are not already activated 
upon entering the device, and a non-reactive surface between the stimulating and analyzing 
patches to allow transient relaxation of stimulated cells to test signal reversal in the cells. 
To meet these specifications requires a patterning technique for making protein patches 
with high-precision registration, desired pattern positions, and minimum protein 
contamination, which are beyond the capabilities of existing technologies. 
 In this chapter, we report a patterning method that combines microcontact printing 
and microchannel coating to achieve gapless auto-aligned patterning of multiple protein 
patches (Figure 2-1 b). This new approach of micro-patterning allows the placement of 
target ligands at well-defined locations, which can be useful for studies of cell adhesion 
mediated by a range of receptor–ligand species [83, 84] and for certain biological assays 
such as combinatorial screening [83] and cell sorting [84]. As a demonstration, we applied 
this method to interrogate the activation of platelets by GPIb—ligand binding, using αIIbβ3 
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activation and expression of P-selectin as readouts. Our results demonstrate the validity of 
this technical platform and show that the platform parameters can be designed to control 
the level of activation and its reversal. Finally, we show a potential utility of this platform 
in preclinical diagnostics by using it to assess platelet hyperreactivity in diabetic patients 
with a drop of whole blood. 
 
2.2 Materials and methods 
2.2.1 Proteins and chemicals 
 Monoclonal antibodies (mAbs) LIBS2 (ab62, Millipore, Billerica, MA), HIP8 
(Thermo Fisher Scientific, Waltham, MA) and AK4 (Thermo Fisher Scientific) were used 
to coat protein patches. LIBS2 binds the β tail domain of integrin αIIbβ3, the epitope of 
which is exposed only when the integrin takes an extended conformation [85]. By 
comparison, HIP8 binds αIIbβ3 in a conformation-independent manner [86]. AK4 
specifically recognizes P-selectin [87]. PE-labelled anti-A1 mAb 6G1 and FITC-labelled 
anti-fibronectin mAb ab2413 were from Abcam (Cambridge, UK) and used to visualize 
ligand coating. 
 GPIb ligand VWF-A1 was a gift from Zaverio Ruggeri from the Scripps Research 
Institute (La Jolla, CA). Integrin αIIbβ3 ligand fibronectin fragment (the 9-10 domains of 
fibronectin III) was a gift from Andres J. Garcia from the Georgia Institute of Technology 
(Atlanta, GA). Biotin-PEG3500-NHS were from JenKem (Plano, TX). ADP, thrombin, 
dimethyl sulfoxide (DMSO), apyrase, clexane, bovine serum albumin (BSA) and other 




2.2.2 Blood samples and platelet purification  
 Blood samples were drawn from volunteers who signed informed consent 
according to protocols approved by the Institute Review Boards of the Georgia Institute of 
Technology and Emory University. Blood was drawn by venepuncture from healthy 
subjects (20–30 years of age) or patients with type 1 diabetes (8–18 years of age) by trained 
nurses according to procedures approved by the Institutional Review Boards of the Georgia 
Institute of Technology and Emory University, respectively. Blood was drawn using a 19G 
butterfly needle into acid citrate dextrose containing theophylline (ACD: 85 mM sodium 
citrate (2H2O), 72.9 mM citric acid (anhydrous), 110 mM G-glucose, 70 mM theophylline, 
diluted 7× with dH2O), mixed well, and transferred to a 10 ml tube with 0.005 U ml−1 
apyrase. Whole blood was used directly. To prepare washed platelets, blood was placed at 
37 °C for 15 min and then centrifuged for 10 min at 200g. Platelet rich plasma was 
transferred from the supernatant to fresh tubes and centrifuged again at 1700g for 5 min. 
The supernatant was discarded, and the platelet pellet was re-suspended in a platelet 
washing buffer (PWB: 43 mM K2HPO4, 43 mM Na2HPO4, 243 mM NaH2PO4, 1.13 M 
NaCl, 55 mM D-glucose, 100 mM theophylline, diluted 10× with dH2O, pH 6.5, 
conductivity 13–15) plus clexane (20 U ml−1) and apyrase (0.01 U ml−1). The platelet 
suspension was then centrifuged at 1500g for another 5 min. After discarding the 
supernatant, the platelet pellet was re-suspended at <1 × 109 ml−1 in Tyrode's buffer (120 
mM NaHCO3, 100 mM HEPES, 1.37 M NaCl, 27 mM KCl, 55 mM D-glucose, diluted 
10× with dH2O, pH 7.3, conductivity 13–15) containing BSA (5 mg ml−1) and apyrase 
(0.02 U ml−1). The platelet suspension was placed in a 37 °C water bath for 30 min. The 
suspension was diluted to 1 × 108 platelets per ml for use in experiments. 
 
2.2.3 Device design requirements and fabrication 
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 Standard soft lithography was used to fabricate devices in polydimethylsiloxane 
(PDMS, Corning Sylgard 184, Midland, MI). Two matched silicon wafers were fabricated 
(SU8-2025, MicroChem). The first is a one-layer mold with a 25 μm-thick single layer for 
microchannel PDMS. The second is a two-layer mold, 25-μm thick each for stamping 
PDMS. The features on the transparency mask were transferred with UV photolithography. 
The surface of wafers was treated with tridecafluoro 1,1,2,2-tetrahydrooctyle-1-
trichlorosilane vapor from United Chemical Technologies (Lewistown, PA) to facilitate 
release of PDMS from the mold. A mixture of PDMS (PDMS base and crosslinker in a 
10:1 ratio) was poured on the mold and the whole preparation was left for curing for 2 h at 
95 °C. After peeling off the PDMS, the devices were cut into shape and access holes were 
punched using 19 gauge needles (McMaster-Carr). 
 Plastic clamp holders were laser-cut with holes matching the inlets and outlets. 
Plastic holders and screws were applied to hold the PDMS device and glass substrate 
together. After assembly, the device was primed in vacuum to remove bubbles. The chip 
was connected to syringe pumps to deliver flow for protein coating. 
 
2.2.4 Protein pattern design and preparation 
 Resting platelets in dynamic flow are able to bind immobilized VWF-A1 but not 
FN, which only binds activated platelets. In our basic design (Figure 2-1 b), therefore, after 
passing BSA blocked area, flowing platelets would first encounter a FN patch 
(preprocessing, zone A) to confirm the resting state of the platelets prior to stimulation 
(negative control). The resting platelets would travel downstream to encounter a VWF-A1 
patch (stimulation, zone B) for controlled stimulation. Stimulated platelets would then 
travel further downstream to a relaxation zone C before encountering another FN patch 
(reporting, zone D) for reporting of platelet activation as assessed by ligand binding by 
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integrin αIIbβ3. To achieve this design, BSA was stamped onto zone C by microcontact 
printing. FN was delivered via a microchannel to zones A and D with a concentration of 
0.016 or 0.16 μg/ml, and incubated for 1 h. VWF-A1 was then delivered via another 
microchannel to zone B with a concentration of 100 μg/ml and incubated for 1 h.  
 We also used two variations of the above basic design after it was fully validated. 
In the first variation, a conformation reporter mAb for integrin αIIbβ3 (LIBS2) or a 
conformation-independent mAb (HIP8) was coated in zones A and D instead of FN. In the 
second variation, a mAb against P-selectin (AK4) was coated in zones A and D to detect 
the upregulated expression of P-selectin. 
 We fixed the length of zones A and D to be 800 µm, long enough for analysis of 
platelet binding. We varied the length of zone B to program different stimulation time doses 
of stimulation in the device. We also varied the length of zone C to assess the sustainability 
and reversal of activation (Figure 2-1 b). 
 
2.2.5 Quantification of cell binding and protein coating 
 The experiment was monitored using an inverted microscope (Leica EMIRBE) 
with a CMOS camera (Hamamatsu Orca) at 40X magnification. Phase-contrast mode was 
chosen for both video recording and image acquisition. Mean velocities of 15-20 rolling 
cells were measured for each condition with 9 fps video recording with frame by frame 
analysis via ImageJ software (ImageJ V1.48 National Institutes of Health) off-line. The 
experiment was repeated 3 times. The end-point assay was applied by counting the 
adherent cell number per mm2 over an area of 36200 μm2 after 2 min of continuous flow 
for 2 random fields of view. Each condition was repeated in 3 devices for each sample. 
Statistical comparisons were performed using the unpaired Student t-test. 
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 Epifluorescence mode of an EMCCD camera (Hamamatsu Orca) was used to 
visualize the coating of FN and VWF-A1 using FITC-labelled ab2413 and PE-labelled 6G1 
at saturating concentration (100 μg/ml each), respectively. 
 
2.3 Multi-zone microfluidic device 
2.3.1 Design 
 Our device design requirements are based on the initial application, which is to 
characterize receptor–ligand mediated platelet activation. The multiple surface zones 
should test the activation state of the platelets prior to controlled stimulation, stimulate the 
platelets and report the activation state afterwards. Several proteins are to be displayed with 
controllable density and good spatial registration to each other. The spatial resolution of 
the patterning should be on the order of the size of a platelet (which is 3-μm in diameter). 
This accuracy is required considering the fast signalling kinetics (seconds) and 
translocation velocity (a few µm/s) of platelets interacting with immobilized ligands. 
Furthermore, since platelet stimulation by GPIb–VWF-A1 mechanoreception alone is 
transient [8], testing platelet activation immediate after stimulation is preferable. Hence, 
gaps between zones should be kept as small as possible.  
 To achieve auto-alignment for surface patterning in the microchannels, we take 
advantage of the two existing techniques - microcontact printing and laminar flow 
patterning (Figure 2-2). The key of the process is to protect regions using physical masking 
or stamping of a non-ligand protein (e.g. BSA), and sequentially pattern different proteins 




Figure 2-2 Process of patterning four proteins on four zones without gaps. The 
procedures are shown on the left. The resulting patterns are shown on the right. 
a) Two pieces of PDMS with nearly matched shapes to allow the stamping 
PDMS (I, bottom, light grey) pre-coated with BSA (blue) to print BSA on the 
microchannel PDMS (II, top, light blue). b) Upon contact, BSA was transferred 
from the upper surface of the stamping PDMS to the bottom surface of the 
microchannel PDMS except for the area boxed by the dashed red box. c) The 
microchannel PDMS stamps on and transfers the BSA onto a substrate glass, 
forming a protein patch on the relaxation zone C and also blocking the areas 
from the inlet to zone A and from zone D to the outlet. d) Two protein solutions 
flow through two microchannels (arrows) to coat zones A and D. e) A flow 
chamber is assembled by placing another piece of PDMS (III, white) on top of 
the substrate glass with flow direction perpendicular to the protein stripes. 




 The process is as follows. First, a stamping PDMS piece is pre-coated with BSA 
(I); it is put into contact with a piece of PDMS bearing microchannels with matched 
geometries (II) (Figure 2-2 a). This allows BSA to be transferred from the stamping PDMS 
to the microchannel PDMS piece wherever they are in contact. There is a region, however, 
where the height of the stamping PDMS is smaller than the depth of the channel PDMS 
piece. This area in the channel between the ridges is left blank (Figure 2-2 b, dashed red 
rectangle). The microchannel PDMS is then brought into contact with a glass substrate for 
two simultaneous actions: (1) to transfer BSA to the non-targeted areas and relaxation zone 
C, and (2) to create two microchannels for protein coating of glass via physical absorption 
of proteins from solutions that are pumped through (Figure 2-2 c). This step creates protein 
patterns in zones A and D on the glass surface, while leaving the middle area blank because 
of the protective ridges (Figure 2-2 d). BSA is then delivered through the channels to 
further block any uncoated areas on zones A and D so that later procedures do not 
contaminate them. A third piece of PDMS (III) containing the channel for cell delivery is 
then sealed to the surface (Figure 2-2 e). Flowing another protein solution through this 
channel allows zone B to be coated with no impact to the other zones because they are 
protected by the previously coated target proteins or BSA. As a result of this process, four 
protein patches can be patterned on the glass surface with all other areas blocked by BSA. 
Because the patterns are registered by the PDMS geometries, this approach is advantageous 
in that the protein patches are guaranteed to align automatically. 
 
2.3.2 Characterization of the protein pattern 
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 we assessed the registration of this approach by patterning the glass surface with 
two proteins, fibronectin (FN) and VWF-A1, and visualizing the protein patterns using 
their respective antibodies conjugated with two different fluorophores (FITC for FN, and 
PE for VWF-A1). Epifluorescent images of the patterned surface show uniform antibody 
staining with sharp edges in individual channels, and no overlaps when images from the 
two channels were registered to each other (Figure 2-3 a). To assess the accuracy of the 
registration, we quantified these images by taking fluorescence intensity line-plots 
perpendicular to the patterned stripes (Figure 2-3 b). The protein patterns have sharp and 
well-defined edges and relatively uniform distribution throughout the stripe. These data 
collectively validate the method for its ability to pattern multiple proteins with precise 
spatial registration and negligible cross contaminations. 
 
Figure 2-3 Assessment of protein coating quality. a) A three-zone device without 
zone C was coated with fibronectin (FN) in zones A and D and VWF-A1 in zone 
B. The two proteins were detected by their respective mAbs tagged by two 
different fluorophores and viewed by epi-fluorescence microscopy via the FITC 
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(green) channel for FN (top), PE (red) channel for A1 (middle) or both channels 
(bottom). Scale bar is applicable to all images. b) Intensity distributions of the 
two fluorescent antibodies along a line in the flow direction. c) Density and 
uniformity assessment of VWF-A1 coating. Three independent replicate tests 
were performed (indicated by different colors) using different devices coated 
with indicated concentration of VWF-A1. Each dot indicates intensity over one 
20X20 μm2 square. Two representative images were shown for VWF-A1 coating 
with concentration of 20 and 100 µg/ml, respectively. 
 
 To determine the consistency and robustness of the method, we measured the 
fluorescence intensity of the anti-VWF-A1 mAb in three independent trials using three sets 
of devices (Figure 2-3 c). Coating concentration of A1 was varied from 10 to 100 μg/ml 
for each set on different days. Fluorescence intensity increases with increased 
concentration. Under the same coating concentration and microscope setting, intensities 
for different devices were comparable on different days, suggesting that these procedures 
are quantitatively replicable. Together, these data suggest that our coating strategy can 
yield controlled and consistent surface density of the coated proteins. 
 
2.3.3 Validation by platelet activation on multizone device 
2.3.3.1 Examine platelet rolling velocity on multiprotein patches 
 We next tested the ability of our device to separate the two pairs of receptor-ligand 
cooperative binding (GPIb and integrin αIIbβ3) in space and time by measuring the 
velocity of platelet rolling on the respective ligands. In a device coated with FN only in 
zone D, washed platelets flowed passed the surface showing no sign of interaction 
regardless of shear rate, a condition serving as negative control [88] (Figure 2-4, annotated 
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as ‘do not roll’). Rolling platelets were observed over the stimulation zone, confirming the 
transient interaction of platelet GPIb with the surface VWF-A1 The rolling velocity first 
decreased with increasing wall shear stress of the flowing fluid, reached a minimum at 4 
dynes/cm2, and then increased with further increase in wall shear stress (Figure 2-4, 
squares), which is consistent with the previously reported catch-slip bond characteristic of 
GPIb–VWF-A1 binding [89]. We have also summarized the fraction of rolling cells under 
these conditions (Table 2-1). 
 
Figure 2-4 Platelet activation by VWF-A1 and ADP demonstrated by decreased 
rolling velocity on FN. Velocity of platelets rolling on surfaces patterned with 
indicated proteins is plotted vs. wall shear stress. Quiescent platelets (no 
treatment) did not interact with FN surface (0.016 µg/ml, coating concentration) 
in zone A (data not plotted), but rolled on VWF-A1 surface (100 µg/ml, coating 
concentration) in zone B (square) and FN surface (0.016 µg/ml, coating 
concentration) in zone D (diamond). (This device has no zone C.) Rolling velocity 
on FN surface after VWF-A1 stimulation was significantly lower than on VWF-
A1 surface. As a control, platelets pre-treated with 50 µM ADP for 15 min rolled 
on zone A with significantly lower velocity (circle). Data are presented as mean ± 
sem of 15-20 cells. Experiment was repeated 3 times with consistent results and 
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the representative data are shown. *, ** and *** denote p < 0.05, 0.01 and 0.001 
by Student t-test. 




2 4 8 20 40 
FN no detectable binding 
A1 75.8% 85.4% 90.2% 84.3% 89.4% 
FN (A1 triggered)     77.3% 84.2%   
FN (ADP 
triggered) 
  84.1% 78.1% 83.0%   
 
 It is known that GPIb interaction with VWF-A1 stimulates platelets, and promotes 
interactions with the downstream reporting zone surface coated with FN [90]. High density 
coating of FN (0.16 µg/ml coating concentration) firmly arrested the stimulated platelets, 
whereas low FN density (0.016 µg/ml coating concentration) supported their slow rolling 
(Figure 2-4, diamond), both of which indicated the activation of platelet surface αIIbβ3 with 
an increased ligand binding affinity after VWF-A1 stimulus. As a positive control, washed 
platelets were incubated with a soluble agonist ADP (50 µM, 15 min) and perfused through 
a device with only low density of FN coating [90]. Rolling velocity of ADP-treated 
platelets without VWF-A1 stimulation was significantly lower than platelets stimulated 
with VWF-A1 (Figure 2-4, circle). These data confirm that platelet activation can be 
achieved by interacting with a surface coated with A1, and this activation is weaker than 
the chemical agonist stimulation. This set of experiments also demonstrates that our device 
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allows triggering of cell activation and follow-up characterization of stimulated cells with 
control of the sequential timing of ligand presentation. 
 
2.3.3.2 Platelet adhesion on ligand FN 
 It is reasonable to assume that the signaling amount of a cell can depend on the 
amount of stimulation it receives. While the stimulator dosage of a soluble agonist can 
easily be controlled, controlling the dosage of VWF-A1 stimulation is challenging. Indeed, 
how platelet activation via VWF-A1 binding is stimulation time-dependent was poorly 
characterized in the literature. Thus, we next characterized the stimulation time-
dependency of integrin αIIbβ3 activation upon the stimulation on GPIb, which is realized 
via pre-programing the stimulation time in the device hardware. In our assay system, the 
stimulation time for platelets depends on both flow rate and the length of zone B. However, 
changing the flow rate would also change the wall shear stress, which would affect GPIb 
bond lifetimes with VWF-A1 and also platelet mechanosensing [89, 91]. Therefore, we 
made a set of devices with variable zone B lengths (50-800 μm). For a given flow rate and 
device dimensions, the longer the zone B, the longer the potential time for platelets to be 
stimulated by sequential and intermittent binding of VWF-A1. Washed platelets were 
perfused through devices with zone B of variable lengths, zone C of zero length, and zone 
D coated with high coating concentration of FN (0.16 µg/m) to arrest VWF-A1 stimulated 
platelets. 
 The effect of varying the stimulation time was assessed by measuring the number 
of adherent platelets per unit area in zone D (Figure 2-5). Increasing stimulation time when 
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zone D is relatively short (zone B length from 50 to 200 μm) resulted in a drastic initial 
increment in the number of adherent cells. The activation approached saturation when zone 
B length reached 400 μm, because further increasing the length to 800 μm did not yield 
more platelet adhesion. These experimental results are robust and reproducible in 
independent experiments on different days. This also the first demonstration of platelet 
activation by VWF-A1 being stimulation time dependent. 
 
Figure 2-5 Characterization of platelet activation and relaxation. Protein 
patterns were made to test the effects on platelet binding to reporting zone 
coated with 0.16 µg/ml FN of variable length of a) stimulation zone coated with 
100 µg/ml A1 and b) BSA-blocked relaxation zone. The protein patterns used in 
panels a have no zone C. Experiments were done by perfusing 1 × 108 
platelets/ml for 2 min. Each point represents measurement from one flow 
chamber. Different symbols indicate data obtained from different donors. Every 
donor donated blood twice for repeated experiments. *, **, *** and **** denote, 
p < 0.05, 0.01, 0.001 and 0.0001, respectively, by Student t-test. 
 
 The intracellular Ca2+ flux triggered by GPIb is highly transient, which can fade 
away within seconds [9]. It is therefore reasonable to question the temporal stability of the 
integrin αIIbβ3 activation triggered by GPIb, which is downstream of Ca2+ flux. With the 
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same device, one is also able to investigate this temporal stability by pre-programming 
variable relaxation times with different zone C lengths in the device hardware. With 
blocking protein BSA on zone C, platelets are prevented from receiving any additional 
stimulation during the relaxation time, which varies from short (~5 s for 200 μm zone C) 
to long (~30 s for 1200 μm zone C), before entering the reporting zone. Again, zone D was 
coated with FN (0.16 µg/ml) and the effect of varying relaxation time was assessed by 
measuring the number of adherent platelet per unit area in zone D (Figure 2-5 b). Little 
decrease in adherent cell density was observed when relaxation time was short (length <400 
μm). However, a steep decrease occurred when zone D length increases from 400 to 800 
μm. The effect saturates beyond 800 μm. These experiments showed that platelet activation 
by VWF-A1 stimulation was transient (in the time scale of minute) and reversible when 
platelets received no further stimulation. 
 
 
Figure 2-6 Characterization of the effect of accumulated platelets. FN was coated 
on device with or without VWF-A1 ahead. Platelets adhered on surface after 
various time span were recorded without VWF-A1, and 2min with A1 
stimulation was also plotted as a reference. No significant increase in platelet 
adhesion was observed, but all significantly lower than the A1-stimulated 
condition. Each point in a and b represents measurement from one flow 
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chamber. *, **, *** and **** denote, p < 0.05, 0.01, 0.001 and 0.0001, 
respectively, by Student t-test. 
 We also performed another control to eliminate the alternative effect of VWF-A1 
that brings platelets to the surface so accumulated more platelets adhered to the FN zone 
rather than stimulate the cells. In this control experiment, platelets were perfused over FN 
in various time spans without pre-actication by A1. No signifcant increase in platelet 
adhesion with longer perfusion time (more platelets) was observed, and all adhesion levels 
were significantly lower than that with pre-activation by VWF-A1. So even if VWF-A1 
may help collect relatively more adhesive platelets, the effect is neglectable. 
2.4 Parallel multi-zone device 
 A titration-like characterization of stimulation amount on platelets demonstrated 
that the cell activation by immobilized ligands was also stimulation dose-dependent in this 
chapter. When exploring the activation and/or relaxation conditions for cells, a range of 
stimulation doses is required. A thorough characterization of the cell activation also 
requires a variety of antibodies and ligand in the reporting region. Only one stimulation 
dose on a device is relatively labour intensive for researchers, especially in the exploration 
stage. A platform with various conditions parallel is beneficial for throughput purpose and 
condition control. With such a platform, researchers will be able to perform experiments 
for various conditions in a single run, at the same time, reducing variations resulting from 
device-to-device and time-to-time. 
 In this part, we described a more advanced version of multi-zone device – parallel 
multi-zone device. Not only this enables the researchers to scale up the device for various 
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stimulation and/or relaxation conditions, but also lessening the variation effect from the 
device and cell variability due to experimental time. 
2.4.1 Design 
 To achieve this parallel multi-zone device, we modified the stamping PDMS and 
its matched microchannel PDMS (Figure 2-2 b, Figure 2-7 a) to be asymmetric. Instead of 
straight coating channel, they have changing dimensions along the protein coating channel, 
perpendicular to the experimental flow chamber (Figure 2-7). For instance, we designed a 
device with four dimensions for both the stimulation region and relaxation region. 
 
 
Figure 2-7 Illustration of the principle of the parallel multi-zone device. The 
channel PDMS are shown on the top. The resulting patterns are shown on the 
bottom. a) The microchannel PDMS was previous contacted by its matching 
PDMS carrying blocking protein BSA as in Figure 2-2 a and b. Upon contact 
with glass, the rest was blocked by BSA except for the middle wall. That resulted 
a blank area (white) in the glass surface. Area A (green) and C (yellow) were 
coated by two protein solutions flowing through two microchannels. b) A device 
with several flow chambers was then assembled by placing another piece of 
PDMS on top of the substrate glass with flow direction perpendicular to the 
protein stripes. Protein solution B then be coated (red). Asymmetricity can be 




 The multi-zone device shares the same assembling process as the single multi-zone 
device described in Figure 2-2. The key change of this device is to have an asymmetric 
channel and/or channel wall (Figure 2-7 a). Thereupon, protein patterns have various sizes 
across the substrate glass. When one applies the final PDMS device with a set of channels, 
each channel contains different lengths of zones. Any individual zone or several zones can 
be modified to be the varying zone(s). Here one zone, A, was illustrated as an example. 
 The microchannel PDMS was pretreated as figure 2 a and b. It is then brought into 
contact with a glass substrate for two simultaneous actions: (1) transfer BSA to non-
targeted areas, and (2) to create two microchannels for protein coating of glass via physical 
absorption of proteins from solution delivered through. This step created the protein 
patterns A and C. Note that patch A has a changing size across the substrate glass. BSA is 
then delivered through these channels to further block any uncoated areas on zones A and 
C so that later procedures do not contaminate them. Another piece of PDMS is then sealed 
to the surface with the channels perpendicular to the protein zones (Figure 2-7 b). Flowing 
through the protein solution in channels allows zone B to be coated with no impact on the 
other zones since they are protected previously. Thus, individual channels have a different 
size of zone A. These individual channels share the common inlet in practice, hence a single 
experiment can generate a set of various conditions. 
2.4.2 Characterization of protein pattern 
 To realize the various zone size for individual channels but keep the size constant 
within a flow channel, we designed the patterning size with step increase instead of a 
continuous size change. However, these steps would easily cause an uneven coating on the 
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step edges due to bubble formation. To prevent the uneven coating affect the quality of the 
protein patches within individual flow channels, we designed the space of the flow channel 
twice of the size of a step edge fillet. 
 
Figure 2-8 Assessment of the protein coating in individual flow channel. a) A 
three-zone device with only A and C coated with proteins, VWF-A1 and FN 
respectively. These two proteins were detected by their respective mAbs tagged 
by fluorophore PE and imaged by epifluorescence microscopy via N3 channel. b) 
The solution with fluorophore FITC was pumped in flow channels to visualize 
individual channels, by fluorescence microscopy via GFP channel. Dashed line 
indicated the edge of the flow channels. Slight uneven coating caused by the step 
of the protein patches was located between each channels.  
 
 We then assessed the registration of protein patches with flow channels by 
patterning with two proteins, VWF-A1 and FN, and visualizing the protein patches and 
flow channels with fluorophores (PE for protein patches and FITC for flow channels). 
Epifluorescent images of the patterned surfaces show the uniform and staining with sharp 
edges (Figure 2-8 a). There were slight uneven coating areas at the increased step edges. 
But they were all located between individual flow channels, indicated by the dashed lines 
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that derived from the fluorescent image of the individual flow channels (Figure 2-8 b). 
Flow channels were imaged by the same epifluorescent microscopy but in the GFP channel 
as a solution containing FITC fluorophore was pumped in. Hence, within the individual 
flow channels, protein patches are uniform and have clear edges; while across them, there 
are zones with various sizes to explore sizes effect to cell receptor crosstalk. 
2.5 Conclusion 
 We developed an approach for fabricating microfluidic devices that achieves 
gapless protein patterning with auto-alignment for multiple protein zones. Using this 
approach, our microfluidic devices achieved sequentially laid-out protein patterns with 
well-controlled spatial registration and protein density. This system is useful for studying 
multi-receptor adhesion and signalling cascades such as those seen in 
hemostatic/thrombotic process, inflammatory reactions, and adaptive immune response. In 
this work, as a demonstration, we applied devices made using this approach to study 
platelet activation by GPIb mechanoreception through VWF-A1 binding. We characterized 
that such activation was dose-dependent, whereby the stimulation dose needed to achieve 
activation at saturation was measured. The device also allowed further investigation on the 
reversibility of this activation, and the quantification of its time scale. 
 We further developed a parallel multi-zone device based on the initial version for 
better variation control and throughput. With this parallel device, we are able to perform a 
series of stimulation doses for multi-receptor crosstalk and cell activation.  
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 We envision that this device could be widely applied to the study of cell activation 
and diagnostic of cell malfunction in a diversity of biological systems, taking advantage of 




CHAPTER 3. CELL ACTIVATION AND RECEPTOR 
CROSSTALK ON MULTI-ZONE DEVICE 
3.1 Introduction 
 One type of cells could have several distinct physiological functions; one important 
reason is that cells can be activated through various pathways and to distinct activation 
states. For instance, platelets can be activated through mechano-signaling pathways and 
chemo-signaling pathways, the former of which can be further categorized to the GPIb [92] 
and the GPVI pathways [93] and the latter of which categorized to the P2Y1/P2Y12 [94, 95] 
and the PAR1/PAR4 [96] pathways. Similarly, neutrophils [14, 97] and lymphocytes [48] 
have their distinct activation pathways by mechano-signaling and chemo-signaling. 
Understanding of the various mechanistic pathways of cellular functions allows us to 
inhibit some pathological functions of a cell type but leave other normal functions intact 
by specifically suppressing one pathway.  
 However, the abnormality of cells in pathological conditions can be very subtle, 
such as platelets in diabetes, which are hyperactive but have a perfect discoid shape 
(indicates inactive state) [41, 98]. A general antithrombotic therapy would increase the risk 
of bleeding due to the indiscrimination of the inhibition on hemostasis and thrombosis. It 
is essential to understand the subtle differences through well characterization of different 
pathways so the specific pathway resulting abnormity may be targeted. 
 Stimulation dose control and temporal information are fundamental to activation 
state characterization. Relatively easy for titration of chemical stimulus, it is effortful to 
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control mechanical stimulation dose. Our multi-zone platform allows the fine tuning of 
activation dose and characterization of the resulting adhesion behavior, and so enables 
assessment of subtle differences of stimulation responses. Thus, it is an excellent tool for 
questions like this.  
 With the power of the platform, we were able to assess the mechanical activation 
pathway of platelets compared to the chemical and reveal the subtle difference of diabetic 
platelets. Moreover, a spatial separation of ligands resulted in a temporal ligand sensation 
of cells; we demonstrated separation of stimulation and function in neutrophils, assessed 
the time course of activation and stability of the activation states. We also investigated the 
effect of two stimulation components, zone length and coating density, to the resulting 
rolling behavior of neutrophils. 
 
3.2 Materials and methods 
3.2.1 Proteins and chemicals 
3.2.1.1 Platelet study 
 GPIb ligand VWF-A1 was a gift from Zaverio Ruggeri from the Scripps Research 
Institute (La Jolla, CA). Integrin αIIbβ3 ligand fibronectin fragment (the 9-10 domains of 
fibronectin III) was a gift from Andres J. Garcia from the Georgia Institute of Technology 
(Atlanta, GA). Biotin-PEG3500-NHS were from JenKem (Plano, TX). ADP, thrombin, 
dimethyl sulfoxide (DMSO), apyrase, clexane, bovine serum albumin (BSA) and other 
chemicals were from Sigma-Aldrich (St. Louis, MO) unless stated otherwise. 
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 AP5 was from P. Newman (BloodCenter of Wisconsin). PAC-1 was from BD 
Biosciences. ab62 (LIBS-2) was from EMD Millipore, HIP8 was from Thermo Fisher 
Scientific, SZ22 was from Beckman Coulter, and MBC370.2 was from Kerafast. 
3.2.1.2 Neutrophil study 
 K2EDTA was from BD Biosciences (San Jose, CA). HI-111 was from Fisher 
Scientific (Hampton, NH). MEM-148 (anti-Integrin Beta 2) was from Santa Cruz 
Biotechnology (Dallas, TX cat. # sc-51651). mAb m25 was from BioXcell (West Lebanon, 
NH). rHuman ICAM-1/Fc Chimera was from R&D (Minneapolis, MN, cat. # 720-IC). P-
selectin was a gift from Dr. Rodger P. McEver from University of Oklahoma Health 
Sciences Center (Oklahoma City, OK). EasySep human neutrophil isolation kit was from 
STEMCELL Technology (Cambridge, MA). 
3.2.2 Blood samples and platelet purification 
 Blood samples were drawn from volunteers who signed informed consent 
according to protocols approved by the Institute Review Boards of the Georgia Institute of 
Technology and Emory University. Blood was drawn by venepuncture from healthy 
subjects (20–30 years of age) or patients with type 1 diabetes (8–18 years of age) by trained 
nurses according to procedures approved by the Institutional Review Boards of the Georgia 
Institute of Technology and Emory University, respectively. Blood was drawn using a 19G 
butterfly needle into acid citrate dextrose containing theophylline (ACD: 85 mM sodium 
citrate (2H2O), 72.9 mM citric acid (anhydrous), 110 mM G-glucose, 70 mM theophylline, 
diluted 7× with dH2O), mixed well, and transferred to a 10 ml tube with 0.005 U ml−1 
apyrase. Whole blood was used directly. To prepare washed platelets, blood was placed at 
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37 °C for 15 min and then centrifuged for 10 min at 200g. Platelet rich plasma was 
transferred from the supernatant to fresh tubes and centrifuged again at 1700g for 5 min. 
The supernatant was discarded, and the platelet pellet was re-suspended in a platelet 
washing buffer (PWB: 43 mM K2HPO4, 43 mM Na2HPO4, 243 mM NaH2PO4, 1.13 M 
NaCl, 55 mM D-glucose, 100 mM theophylline, diluted 10× with dH2O, pH 6.5, 
conductivity 13–15) plus clexane (20 U ml−1) and apyrase (0.01 U ml−1). The platelet 
suspension was then centrifuged at 1500g for another 5 min. After discarding the 
supernatant, the platelet pellet was re-suspended at <1 × 109 ml−1 in Tyrode's buffer (120 
mM NaHCO3, 100 mM HEPES, 1.37 M NaCl, 27 mM KCl, 55 mM D-glucose, diluted 
10× with dH2O, pH 7.3, conductivity 13–15) containing BSA (5 mg ml−1) and apyrase 
(0.02 U ml−1). The platelet suspension was placed in a 37 °C water bath for 30 min. The 
suspension was diluted to 1 × 108 platelets per ml for use in experiments. For activation 
by ADP or thrombin in BFP or flow chamber experiments, the platelet suspension was 
incubated with ADP or thrombin for 15 min before experiment. 
3.2.3 Blood samples and neutrophil purification 
 Blood was drawn using a 19G butterfly needle into a K2EDTA tube containing 
1mM EDTA. Whole blood was then added to 5mLpolystyrene round-bottom tubes, each 
for 2mL whole blood. Isolation cocktail (50 µL/mL) and well vortexed RapidSpheres (50 
µL/mL) were then added to the whole blood and incubated at room temperature for 5 min. 
Separation buffer (Ca- and Mg- PBS with 1mM EDTA) was added to top up the same to 4 
mL with gentle mixing before placing the tubes (without lid) into the magnet and incubate 
for 5 min. The enriched cell suspension was collected into new tubes and added with 
46 
 
additional RapidSpheres (same volume as before). The purification steps were repeated 
twice before the cells were ready for use. 
 
3.2.4 Microfluidic device fabrication 
 Standard soft lithography was used to fabricate devices in polydimethylsiloxane 
(PDMS, Corning Sylgard 184, Midland, MI). Two matched silicon wafers were fabricated 
(SU8-2025, MicroChem). The first is a one-layer mold with a 25 μm-thick single layer for 
microchannel PDMS. The second is a two-layer mold, 25-μm thick each for stamping 
PDMS. The features on the transparency mask were transferred with UV photolithography. 
The surface of wafers was treated with tridecafluoro 1,1,2,2-tetrahydrooctyle-1-
trichlorosilane vapor from United Chemical Technologies (Lewistown, PA) to facilitate 
release of PDMS from the mold. A mixture of PDMS (PDMS base and crosslinker in a 
10:1 ratio) was poured on the mold and the whole preparation was left for curing for 2 h at 
95 °C. After peeling off the PDMS, the devices were cut into shape and access holes were 
punched using 19-gauge needles (McMaster-Carr). 
 Plastic clamp holders were laser-cut with holes matching the inlets and outlets. 
Plastic holders and screws were applied to hold the PDMS device and glass substrate 
together. After assembly, the device was primed in vacuum to remove bubbles. The chip 
was connected to syringe pumps to deliver flow for protein coating. 
3.3 platelet activation to intermediate state and difference of diabetic sample 
3.3.1 Platelet activation reported by integrin conformation-specific antibodies 
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 After stimulation by VWF-A1, increased binding affinity of αIIbβ3 for FN suggests 
conformational change of αIIbβ3 from the inactive bent conformation to an active extended 
conformation, which would expose the LIBS2 epitope [85]. Similarly, quiescent platelets 
do not express P-selectin, which could be induced upon platelet activation [12]. To further 
characterize VWF-A1 stimulated platelets and demonstrate the utility of the device on 
other proteins, additional tests were performed using the two variations of our basic design, 
which replaced the coating protein FN on zones A and D with a conformation-specific 
mAb against integrin αIIbβ3 (LIBS2) or an anti-P-selectin mAb (AK4), respectively 
reporting the extending conformational change of the integrins and the upregulated 
expression of P-selectin as a result of GPIb signalling. The length of zone C was set to zero 
in these experiments. Stimulation by 800 µm A1-coated zone B resulted in high platelet 
binding to zone D coated with either LIBS2 or AK4 (Figure 3-1). In comparison, platelet 
binding to either antibody was minimal in the absence of A1 stimulation, confirming that 
platelets are in the resting state (Figure 3-1). As a positive control, platelet binding to HIP8, 
a conformation-independent mAb [86], in both zones A and D were indistinguishable, 
suggesting that the increased LIBS2 binding was due to conformational change of integrin 
αIIbβ3, instead of their increased expression level (Figure 3-1).  These experiments 
confirmed our hypothesis that VWF-A1 stimulation on platelets triggers integrin 




Figure 3-1 Platelet adhesion on conformation specific antibodies. Antibodies (100 
µg/ml) were coated on zones A and D to report the conformational change in 
integrin αIIbβ3 (by LIBS2) and upregulation of P-selectin (by AK4) on platelets 
after they were stimulated by A1 in zone B of 800 µm. The conformation-
independent antibody HIP8 was used as positive control, which arrested 
platelets in both zones A and D. By comparison, platelets were able to bind 
LIBS2 and AK4 in zone D but not in zone A prior to A1 stimulation. The protein 
patterns have no zone C. Experiments were done by perfusing 1 × 108 
platelets/ml for 2 min. Data in c are presented as mean ± quarter percentile and 
max/min of 6 experiments. *, **, *** and **** denote, p < 0.05, 0.01, 0.001 and 
0.0001, respectively, by Student t-test. 
 Platelets can be stimulated by different stimulus via distinct activation pathway 
such as GPIb pathway by VWF [92], GPVI pathways by collagen [93], P2Y1/P2Y12 
pathway by ADP [95] and PAR1/PAR4 pathway by thrombin [96]. We applied this device 
characterizing the platelet activation by immobilized ligand VWF-A1 compared with 
soluble agonist ADP stimulation. We measured the platelet ‘dose-dependency’ to 
immobilized VWF-A1 and ADP by either changing the length of the stimulation zone or 
the concentration of the pretreated ADP. A platelet suspension was perfused first through 
the FN zone to confirm their nonadherent resting state. The platelets then translocated on 
and were stimulated by the A1 zone, the length of which varied on different devices, 
providing adjustable doses of mechanical stimulation to platelets. Subsequently, platelets 
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entered the mAb zone to report the αIIbβ3 status. The number of captured platelets on 
MBC370.2 initially increased with the A1 zone length and plateaued at 400 μm, showing 
a mechanical dose dependency of platelet αIIbβ3 extension conformation. Whereas, platelet 
capturing on SZ22 was uniformly high and on AP5 and PAC-1 uniformly low (Figure 3-2 
a), showing no sign of dose dependency. In contrast, adhesion of ADP-stimulated platelets 
in a single-zone flow chamber to surfaces coated with MBC370.2, AP5 or PAC-1, but not 
SZ22, all increased dose-dependently (Figure 3-2 b). 
 
Figure 3-2 Dose-dependent mechanical and chemical activation of integrin αIIbβ3. 
Mean ± s.e.m. (n ≥ 4) platelet density on the indicated mAb zone after 
stimulation by the A1 zone of variable lengths (multi-zone channel; a) or ADP of 
different concentrations (single-zone channel; b). one-way analysis of variance 
(ANOVA) was used to assess whether the points in the same curve were 
significantly different. NS, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001. 
 
 This study suggested the distinctive dose dependencies of αIIbβ3 activation on 
mechanical and chemical stimuli: GPIbα mechano-signaling only upregulated αIIbβ3 to 
the intermediate state, whereas ADP evoked the emergence of active αIIbβ3even at low 
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doses. These different activation outcomes indicate distinct underlying signaling 
mechanisms. 
3.3.2 Testing whole blood and comparing healthy with diabetic platelets 
 Although the use of washed platelets greatly simplifies the system for mechanistic 
study by removal of other blood cells and most plasma proteins, experiments using whole 
blood are obviously more physiological. In addition, should an assay work with whole 
blood, it is more likely to be usable for clinical applications.  The challenge is that since 
whole blood is more biologically complex, experiments on whole blood are potentially 
prone to additional difficulties compared to assays using isolated and washed cells. We 
repeated the experiments as Figure 2-5a on GPIb–αIIbβ3 crosstalk but with whole blood and 
a set of devices with variable zone B length and no zone C. As with purified platelets, 
increased stimulation increased adhesion (Figure 3-3 a). Very low numbers of platelets 
adhered to FN coated zone D if the coating protein to zone B was BSA instead of VWF-
A1, suggesting that platelet adhesion due to potential coating of plasma proteins onto the 
device was negligible under our experimental conditions. A slight increase of stimulation 
time (50 µm zone B coated with VWF-A1) produced a significantly higher number of 
adherent platelets than the BSA background (p < 0.05), which was further enhanced with 
further increasing the zone B length (Figure 3-3 a). However, even when stimulation 
reached saturation (zone B 800 µm), the density of VWF-A1 stimulated platelets was still 
significantly lower (p < 0.01) than platelets pretreated with agonist Mn2+ (10 μM, 15 min), 
which activates platelets to fully activated state. This suggested that the platelets under 
VWF-A1 stimulation were not fully activated. We then made a comparison of our approach 
with conventional coating approach [99] (surface coated with a mixture of VWF-A1 and 
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FN) for studying two pairs of receptor-ligand crosstalk. The mixture coating also yields 
significantly higher adherent platelets due to additional adhesion to VWF-A1. This trend 
is reproduced in two separate donors (Figure 3-3 a). 
 
Figure 3-3 Testing whole blood and comparing diabetic and healthy platelets. a) 
Platelets in whole blood from healthy donors respond to different lengths of 
VWF-A1 (100 µg/ml coating concentration) zone from none (BSA for zone B) up 
to 800 µm. Conditions of platelets pre-activated by Mn2+ (10 μM, 15 min) or in 
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conventional flow chamber (a mixed of VWF-A1 and FN) were also recorded as 
benchmark. b) Protein patterns with varied zone B (VWF-A1 stimulus) were 
used to compare platelets from diabetic and healthy donors. Platelets derived 
from diabetic donors were statistically more responsive than those derived from 
healthy donors even without stimulation (p < 0.05). However, much more 
significant differences were observed when washed platelets were stimulated by 
varied length of zone B coated with VWF-A1. Experiments were done by 
perfusing 1 × 108 platelets/ml for 2 min. c) Comparison on platelets in whole 
blood from both healthy and diabetic donors were made for both conditions of 
no stimulation and VWF-A1 (800 μm) stimulation. Diabetic platelets in whole 
blood were statistically more responsive even without stimulation (p < 0.01), but 
much more significantly with VWF-A1 stimulation (p < 0.0001). Each point in a 
and b represents measurement from one flow chamber. Different symbols 
indicate data obtained from different donors. Different symbol shapes indicate 
different donors. Empty and filled symbols distinguish healthy and diabetic 
samples. n = 4 for healthy donors, n = 2 for diabetic sample. *, **, *** and **** 
denotes p < 0.05, 0.01, 0.001 and 0.0001, respectively, by Student t-test 
 It is known that platelets from diabetic patients are more reactive to external 
stimulations than healthy donors, a phenomenon referred to as platelet hyperreactivity, 
which includes enhanced adhesion and activation of platelets on thrombogenic surfaces 
[98, 100]. Adhesion and mechano-activation are important aspects of platelet function in 
mediating haemostasis and thrombosis. Disturbed shear can induce platelet aggregation 
and thrombus formation in vivo [101]. Therefore, platelet hyperreactivity to mechanical 
stimulations is closely related to thrombosis, a common disease that can be fatal [102]. To 
test whether platelet dysfunction can be determined by our device, we applied our device 
to assay the hyperactivity of platelets from patients with diabetes. We first asked whether 
there would be difference between diabetic and healthy samples without VWF-A1 
stimulation. Washed platelets from diabetes patients and healthy donors were perfused over 
FN without VWF-A1 stimulation in separate devices. Significantly more (p < 0.05) 
diabetic platelets adhered to FN than the healthy group, indicating enhanced binding 
activity of the αIIbβ3 integrins on diabetic platelets before any stimulation (Figure 3-3 b). 
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Notably, much more significant differences between diabetic and healthy platelets were 
observed when the washed platelets were stimulated with additional VWF-A1 stimulation 
(variable length zone B) (Figure 3-3 b). The significance increased with increased A1 
stimulation time (zone B 200 μm, p < 0.005), and even more significant for long A1 
stimulation time (p < 0.0005 for 400 μm and 0.0001 for 800 μm, respectively). These 
results indicate that diabetic platelets are not only pre-activated in blood, but also are more 
reactive upon VWF-A1 stimulation, which is in agreement with their hyperreactivity. 
 Additionally, we compared activity of platelets in whole blood from diabetic and 
healthy donors. In a device where stimulation zone is blocked, significantly more (p < 0.01) 
diabetic platelets in whole blood bind to FN (coating concentration 0. 16 µg/ml) than a 
negative control where the whole device is coated with BSA (Figure 3-3 c). Further, even 
more diabetic platelets bind to FN after VWF-A1 stimulation at 800 μm (p < 0.0001). In 
comparison, healthy platelets only show activity after VWF-A1 stimulation, and 
significantly lower than diabetic platelets upon the same stimulation condition (p < 0.0001). 
These experiments demonstrated the ability of our device in distinguishing diabetic 
platelets in whole blood. Since one drop of blood (10 to 15 μl) is enough for one test, our 
assay can potentially be used for preclinical applications where frequent assessment of 
platelet adhesion behavior is needed. 
 
3.4 Neutrophil activation and rolling on multi-zone device 
54 
 
 We next demonstrated the usefulness of our platform on another biological system, 
neutrophils, to separate the effects of two pairs of receptor-ligand cooperative binding 
(PSGL-1 and integrin LFA-1) (Figure 3-4) in space and time. 
 
Figure 3-4 Neutrophil activation. Integrin LFA-1 can be activated through 
engagement of PSFL-1 to its ligand selectin and then interact with integrin 
ligand ICAM-1. 
 
3.4.1 Neutrophil rolling after activation 
 By measuring the velocity of neutrophil rolling on integrin LFA-1's ligand under 
various shear conditions, we are able to assess the binding properties of the activated and 
non-activated integrins. Similar to the device assembling of platelet activation, a method 
for neutrophil activation to stimulate neutrophils and then monitor cell rolling relying on 
the ICAM-1 behavior, which binds to activated integrins and does not bind to quiescent 
integrin (Figure 3-5). The velocity of neutrophils on the reporting region was measured as 
a function of shear stress for different surface treatments: surface treated with ICAM-1 
only, surface treated with P-selectin surface only, and two surfaces with both ligands but 
different patterns (Figure 3-5 a). On the surface treated only with ICAM ligand, neutrophils 
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were not stimulated and showed no sign of interaction regardless of the shear rate, serving 
as a negative control (Figure 3-5 b, annotated as 'do not roll'). Neutrophils' rolling 
behaviour was observed in the stimulation zone, confirming the transient interaction of 
neutrophil PSGL-1 with the surface immobilized P-selectin. The velocity first decreased 
with the increasing wall shear stress of the flowing fluid, reached a minimum at 0.2-0.3 
dynes/cm2, and then increased with a further increase of the wall shear stress (Figure 3-5 
b, circle). This trend is consistent with the previously reported catch-slip bond 
characteristic of PSGL-1–P-selectin binding [103, 104].  
 
 
Figure 3-5 Neutrophil activation by P-selectin demonstrated by decreased rolling 
velocity on ICAM-1. Velocity of neutrophils rolling patterned with indicated 
proteins is plotted vs. wall shear stress. Quiescent neutrophils (no treatment) did 
not interact with ICAM-1 surface (20 µg/ml) (data not plotted), but rolled on P-
selectin surface (20 µg/ml) (black circle) and ICAM-1 surface (20 µg/ml) in after 
stimulation by P-selectin (blue triangle). Rolling velocity on ICAM-1 surface 
after P-selectin stimulation was lower than on P-selectin surface. As a control, 
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platelets rolling on a surface with P-selectin and ICAM-1 co-presented had a 
lower velocity (red square). Data are presented as mean ± sem of 15-20 cells. 
Experiment was repeated 3 times with consistent results and the representative 
data are shown. 
 
 Neutrophil activation through PSGL-1–P-selectin interaction is known to promote 
the conformation change of integrin LFA-1 [67], and lead to the interactions with the 
downstream reporting zone surface coated with ICAM-1 [105]. The density of ICAM-1 
(20 µg/ml coating concentration) on reporting zone supported the neutrophils' slow rolling 
(Figure 3-5 b, triangle), which indicated the activation of surface protein LFA-1 with an 
increased binding affinity after P-selectin stimulation. As a positive control, the 
conventional flow chamber coating approach was applied: a mixture of P-selectin (20 
µg/ml coating concentration) and ICAM-1 (20 µg/ml coating concentration) was 
immobilized on the device. Neutrophils were able to interact with both proteins at the same 
time, which largely reduced rolling velocity (Figure 3-5 b, square) compared to P-selectin 
only. These data confirm that neutrophil activation and resulting behaviour can be 
separated on our platform. Together with the platelet study, this suggested that this platform 
can be applied to the study of cell activation and function in a diversity of biological 
systems. 
 
3.4.2 Neutrophil activation threshold and intermediate state characterization 
 We next assessed the stimulation dose-dependency and integrin state of neutrophil 
activation via P-selectin binding. 
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 How the activation level of neutrophil via P-selectin binding is stimulation dose-
dependent is not well understood. We characterized the stimulation dose-dependency of 
integrin LFA-1 activation on neutrophils upon the stimulation on PSGL-1 by changing the 
length of the stimulation zone coated with P-selectin (Figure 3-6 a). Purified human 
neutrophils were first perfused through a stimulation zone, the length of which varied in 
different channels, providing adjustable doses of mechanical stimulation via immobilized 
ligand. Subsequently, neutrophils entered the reporting zone coated with a high density of 
ICAM-1 (100 μg/ml coating concentration), where activated integrin LFA-1 interacted 
with ICAM-1 and stopped neutrophil on site. 
 The effect of varying stimulation dose was assessed by measuring the number of 
neutrophils captured per unit area in reporting zone (Figure 3-6 a). When stimulation dose 
remained relatively low (zone length below 400 μm), the number of the adherent cells 
slowly increased with increasing stimulation doses. A significant increase of the number 
of adherent cells resulted for an 800 μm long stimulation pad, and further rose for the 2000 
μm long stimulation zone. A mixed coating of both P-selectin and ICAM-1 served as a 
positive control. Another positive control by pretreatment of Mn2+ for 20 minutes provided 
the reference of neutrophil activation by chemical agonist. Further, these experimental 




Figure 3-6 Stimulation and resulting rolling can be separated in a dose-
dependent manner to show neutrophil intermediate state. The activation of 
neutrophils was reported by their binding to reporting zone coated with a) 
ligand or b) antibodies, after variable length of stimulation zone coated with 20 
µg/ml p-selectin. a) ICAM-1 were coated on the reporting zone to report 
increased adhesion of LFA-1 after stimulation. Conventional flow chamber 
experiments with ICAM-1 and P-selectin co-presented were done as a positive 
control, as well as neutrophils incubated with Mn2+ for 10min. b) Antibodies (100 
µg/ml) were coated to report the conformational change in integrin LFA-1 (by 
Kim 127 for extension conformation, HI-111 for bend conformation and 
MEM148 for open conformation) on neutrophils after they were stimulated by 
P-selectin. The conformation-independent antibody m25 was used as positive 
control, which arrested neutrophils in all stimulation lengths. By comparison, 
neutrophil binding increased to KIM127 and decreased to HI111 with increased 
stimulation dose of P-selectin. Whereas increased stimulation dose was not able 
to increase neutrophil binding to MEM148. Experiments were done by perfusing 
2 × 106 neutrophils/ml for 2 min. Each point in a and b represents measurement 
from one flow chamber. *, **, *** and **** denote, p < 0.05, 0.01, 0.001 and 
0.0001, respectively, by Student t-test (a) and one-way ANOVA (b). 
 Because integrin can be activated to different affinity states corresponding to the 
different conformations, which can be characterized by conformation-specific antibodies, 
we next applied the reporting zone with various antibodies and evaluated the integrin 
activation dose-dependency to the stimulation of the immobilized ligand P-selectin by 
measuring the number of captured neutrophils on conformation-specific antibodies. The 
number of captured neutrophils on HI-111 (indicates bent conformation of integrin LFA-
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1) initially decreased at 800 μm and plateaued at 3000 μm, showing a mechanical dose-
dependency of neutrophil LFA-1 bent conformation. Whereas, neutrophils captured on 
MEM148 (indicates hybrid-domain swing-out) was uniformly low, and uniformly high on 
m25 (for all β2) (Figure 3-6 b), showing no sign of dose dependency. This suggested that 
integrin LFA-1 had an extended but no further swing-out conformation upon P-selectin 
activation, conforming an intermediate activation state of integrin LFA-1 [65, 66]. 
 
3.4.3 Rolling supported by activated integrin is stimulation dose-dependent  
 It is reasonable to assume that the rolling behavior of the neutrophils stimulated by 
P-selectin [66, 97] would be dependent on the stimulation dose as well. We measured the 
rolling velocity of the neutrophils after stimulation of various zones coated with P-selectin 
of different lengths and coating concentrations. The coating concentration corresponds to 
the density of ligand on the surface, and zone length corresponds to the time of a cell travels. 
It is rational to suppose selectin that the length of a coated zone multiplied by the coating 
concentration corresponds to the total amount of ligands a traveling cell can bind to. 
Therefore, we hypothesized that the two effectors, the coating concentration and the length 
of stimulation zone, play a combinatory role as stimulation dose in activating LFA-1. We 
plotted the velocity of the stimulated neutrophils on ICAM-1 (coating concentration 20 
µg/ml) against the stimulation 'selectin dose' (Figure 3-7). The rolling velocities of the 
neutrophils on ICAM-1 surface activated by various coating concentration of P-selectin 
exhibited exponential decrease as stimulation doses increased as expected. Among these 
curves, curves of 5 µg/ml to 20 µg/ml stimulation collapsed into one exponential decay 
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curve. This supported our hypothesis of the effect of the two factors: length and coating 
concentration. The more stimulation dose the neutrophils receive yielded lower rolling 
velocity, indicating a more activated sate of neutrophils. Whereas 50 µg/ml coating 
concentration yielded a different curve, which indicated an exit of the linear regime due to 
possible reasons such as density saturation of the ligand on substrate and occupation 
saturation of the receptor on the cells. 
 
Figure 3-7 Neutrophils roll on multi-zone in a stimulation dose-dependent 
manner. Velocity of neutrophils rolling on ICAM-1 (20 µg/ml) surfaces after 
variable length of stimulation zones is plotted vs. mechano-dose (characterized 
by the length of stimulation zone times coating concentration). Stimulation zones 
were patterned with P-selectin at various concentrations for various lengths 
Neutrophils were perfused in the chambers with a wall shear rate of 50 s-1. Data 
are presented as mean ± sem of 15-20 cells. Experiment was repeated 3 times 
with consistent results and the representative data are shown.  
 
 The rolling behavior on endothelial cells helps neutrophils locate from blood to 
tissue, homing to inflammation sites. We further investigated the rolling behavior of the 
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neutrophils on the asymmetric coating surface for potential heading guided by the patterned 
protein. Instead of a homogeneous reporting zone of ICAM-1, the surface was coated with 
asymmetric stripes of ICAM-1 by stamping, while the space between stripes was blocked 
with blocking protein BSA (Figure 3-8 a). With a forwarding force from flow (from the 
left to the right in Figure 3-8 a), cells tend to move straight forward. However, neutrophils 
could potentially drift laterally at the edge of stripes due to the asymmetric balance of the 
interaction with the ICAM-1. In our experiment, neutrophils interacted only to the ICAM-
1 stripes but not space in between as anticipated (Figure 3-8 b). Extracted trajectories of 
individual neutrophils were plotted in Figure 3-8 c. Each color indicates one neutrophil and 
each dot of that color indicates the location of neutrophil in one frame. Red circles 
highlighted the lateral movement at the edge of the stripes. This lateral movement behavior 
resulted from activated integrin-supported rolling capacitates our device for a potential 
application in cell sorting. 
 
Figure 3-8 Neutrophils roll on asymmetric stripes of ICAM-1. a) illustration of 
the stripes of ICAM-1 surface (blue) and blocking surface (grey). Neutrophils 
were indicated in yellow and their anticipated trajectory in red curves. b) 
Neutrophils rolled and some adhered on the stripe surface of ICAM-1, but not 
the blocking surface. Stripes of protein pattern was indicated by dashed lines. c) 
Extracted individual trajectories of some representative cells. Each color 
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indicates one neutrophil and each dot of that color indicates the location of 
neutrophil in one frame. Scale bar: 100µm. 
 
3.5 Conclusion 
 In this chapter, we expanded the platform on two biological systems, platelets and 
neutrophils, for the crosstalk study of their surface receptors.  
 We validated the activation state and the stimulation requirement for the platelets 
by GPIb-VWF-A1 interaction by characterizing integrin conformation change and P-
selectin expression level in the reporting zone. This study contributed to the discovery of a 
new integrin αIIbβ3 activation state by demonstrating a distinct activation condition via 
immobilized VWF-A1 versus soluble agonist ADP in a dose-dependent manner. Moreover, 
the successful application of this device to assessing whole blood samples implies its 
potential to test a drop of blood, which is compatible with clinical application. Furthermore, 
using whole blood, we detected the pre-activation of diabetic platelets and their higher 
activation level upon VWF-A1 stimulation, which was not easily monitored by other means. 
Altogether, our results indicate that this microfluidic system could serve as a promising 
diagnostic tool for platelet hyperreactivity, which is found not only in diabetes but also in 
many other diseases (e.g., obesity [106], hypertension [40], etc.). 
 We then demonstrated that the neutrophil activation and integrin interaction can be 
separated in spatial and time, which is not easy to show by other means. Further assessment 
on the activation threshold and conformation validated the intermediate state of integrin 
LFA-1 after activated by the interaction of PSGL-1 and immobilized P-selectin. Moreover, 
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we investigated the effect of two stimulation components, zone length and coating density, 
to the resulting rolling behavior of neutrophils on ICAM-1 surface. The collapsed curves 
validated our hypothesis of these two parameters. We further demonstrated activated 
integrin LFA-1 - supported rolling on asymmetric stripes of ICAM-1, which leads to a 
lateral movement on the edge of the stripes. We envision this behavior of the activated 




CHAPTER 4. TCR-PMHC INTERACTION UNDER FLOW 
INDUCES INTERMEDIATE-AFFINITY OF LFA-1 TO SUPPORT 
ROLLING ADHESION 
4.1 Introduction 
 T cell’s critical role in adaptive immunity and the extreme high sensitivity and 
specificity of its recognition to antigen attract intensive interests in the T cell activation 
study [48, 51-53, 55, 57, 107, 108] (Figure 4-1). Distinct triggering models have been 
proposed and modified over the past decades, including affinity-based model [49], kinetic 
proofreading model [50, 51], serial triggering model [55, 56], mechano-sensor model [57, 
58] and so on [44, 59] (details in 1.5.2). Despite the intensive study, this triggering process 
is still under debate. Further observation could help to add more understanding to this 
process. 
 Integrin LFA-1 is expressed on all leukocytes and comprehensively studied in 
neutrophil for its conformation, affinity state and function: bent, resting state of the LFA-
1 results in low affinity to its ligands; extended conformation of LFA-1 supports slow 
rolling; open conformation facilitates firm adhesion which usually require chemokine 
stimulation [67]. After T cell triggering by TCR, one of the most important regulation is 
the integrin LFA-1 activation [65] (Figure 4-1). However, the activation state of this 
predominant integrin remained elusive on T cells. The integrin in an immunological 
synapse (IS) facilitate firm adhesion and demonstrated fully activation state [62], yet the 
formation of an IS could last hours which involves activation processes like chemokine 
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stimulation [109, 110]. It also remained a question whether the activation of the integrin 
requires to be in an IS. 
 
Figure 4-1 T cell stimulation by specific pMHC. Stimulated by specific pMHC, T 
cells can be triggered with a change in integrin LFA-1. 
 New technology development always allows advanced observations that facilitate 
more finding and add knowledge to existing models. With the power of controlling 
mechano-stimulation dose precisely, permitting fast rebinding interaction under flow and 
allowing two receptor-ligand interaction spatially separated, the multi-zone device is an 
excellent tool for the investigation of T cell stimulation under flow and the resulting 
behavior. We applied this platform to study T cell activation under flow by measuring the 
velocity of moving cells on both the antigen surface and integrin ligand surface in a 
separated, dose-dependent manner. Calcium flux monitoring was also added to validate the 
activation and distinguish the calcium pattern of T cells stimulated by pMHC with various 
potency. This study added an observation to the current knowledge of T cell activation, of 
the T cells interacting with surface-immobilized pMHC in a flow condition and triggering 




4.2 Materials and methods 
4.2.1 Chemicals and proteins 
 RPMI 1640 1X w/ L-glutamine was from Corning Inc. (Corning NY). Mouse 
Erythrocyte Lysing Kit was from R&D systems (Minneapolis, MN). Molecular Grade 
Water was from Corning Inc. (Corning NY). Trypan Blue was from Sigma-Aldrich (St. 
Louis, MO). Mouse CD 8+ T cell enrichment kit was from STEMCELL Technology 
(Cambridge, MA). Recombinant mouse ICAM-1-Fc chimera was from BioLegend (San 
Diego, CA). EZ-Link™ NHS-PEG4-Biotin was from ThermoFisher Scientific (Waltham, 
MA). 
pMHCs (including OVA, Q4R7, Q4H7, G4, VSV) were from Emory NIH tetramer core 
facility (Atlanta, GA): OVA (SIINFEKL), Q4R7 (SIIQFERL), Q4H7 (SIIQFEHL),G4 
(SIIGFEKL), VSV (RGYVYQGL). 
4.2.2 Primary mouse T cell purification 
4.2.2.1 Spleen grinding and RBC lysis 
 Mouse spleen was collected into 1mL of R10 buffer (RPMI 1640 1X w/ L-
glutamine, added 100mL FBS, 10mL P/S, 10mL Hepes, and 10mL sodium pyruvate per 
1L RPMI). Together with 3 mL R10 in a 70 µm cell strainer placed on the top of a 6 cm 
petri-dish, collected spleen was grinded using a 3 mL syringe plunger end. The cell 
suspension was collected with 3 mL R10 washing the plunger end, cell strainer and petri 
dish and then centrifuged at 1500 rpm for 7 min. The supernatant was discarded, and the 
cell pellet was resuspended with 2 mL of 1x lyse buffer (dilute 0.2mL of 10X M-lyse buffer 
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in 1.8 mL of molecular grade wafer) and incubated 2.5-3 min at room temperature. The 
reaction was stopped by adding 8 mL of 1x wash buffer (dilute 800 µL of 10x wash buffer 
in 7.2 mL of molecular grade water) to make a 10 mL in total. Cell counting was done by 
taking 10 µL of solution for 10 times dilution with 0.04% Trypan Blue (0.4% Trypan Blue 
diluted with 1x PBS). After cell counting, the solution was centrifuged at 1500 rpm for 9 
min at room temperature before discarding the supernatant.  
4.2.2.2 CD8 T cell purification 
 The splenocyte pellet was resuspended at a concentration of 1×108 cells/ml with 
EasySep Buffer (PBS + 2% FBS) in a 5mL FACS tube, plus Normal Rat Serum (50 µL/mL) 
to prevent non-specific binding and CD8+ T cell isolation Cocktail (50 µL/mL), followed 
by an incubation of 10 min at room temperature. SA Rapid Spheres (125 µL/mL) was 
added and incubated for 5 min at RT before Easy Sep Buffer added to the mixture for a 
total volume of 2.5 mL. The tube was then placed on the EasySep magnet without cap for 
3min. Solution was collected by pouring to a 15 mL tube with an addition of Easy Sep 
Buffer to make a final volume of 5 mL for cell count. Cell solution was centrifuged for 7 
min at RT at 1500 rpm before discarding the supernatant and resuspending in R10 or HBSS 
to make 2 million/ml concentration. 
4.2.2.3 CD8 T cell depletion 
 The splenocyte pellet was resuspended at 100 million/mL in Easy Sep buffer (PBS 
+ 2% FBS). After adding biotin-antiCD8 (cl 53-6.7 0.5 mg/mL) to a final antibody 
concentration of 25 µg/mL, the solution was incubated at 4 degree for 20 min on a rotator. 
The splenocyte solution was then transferred to a 15 mL tube, with additional 10 mL Easy 
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Sep Buffer to stop the reaction before cells resuspended to 100 million/mL in Easy Sep 
Buffer. Dynabeads M-280 streptavidin (125 µL beads per 1 mL of cells) was taken before 
thorough vortexing for a wash with 1 mL Easy Sep. Cell suspension and beads were mixed 
for an incubation of 15 min at 4 degree on a rotator. The cell-bead-mixture was then 
transferred to a 5 mL FACS tube, plus Easy Sep Buffer till a final volume of 2.5 mL before 
placing the tube on an EasySep magnet for 3 min. The liquid was poured gently out into a 
15 mL tube while the FACS tube was kept on the magnet. The solution was then 
centrifuged and resuspended in R10 or HBSS to a concentration of 2 million cells/mL.  
4.2.3 Microfluidic device fabrication 
 Silicon wafers were fabricated in clean room with negative photoresist (SU8 2025, 
MicroChem). Wafers were then used to mold devices in polydimethylsiloxane (PDMS, 
Corning Sylgard 184, Midland, MI) by standard soft lithography. The stamping wafer, the 
coating channel wafer and the experimental device wafer are all one-layer molds for a 25 
μm-thick single layer PDMS for stamping, channel coating and experiment flow. The 
features on the transparency mask were transferred with UV photolithography. The surface 
of wafers was treated with tridecafluoro 1,1,2,2-tetrahydrooctyle-1-trichlorosilane vapor 
from United Chemical Technologies (Lewistown, PA) to facilitate release of PDMS from 
the mold. A mixture of PDMS (PDMS base and crosslinker in a 10:1 ratio) was poured on 
the mold and the whole preparation was left for curing for 2 h at 95 °C. After peeling off 
the PDMS, the devices were cut into shape and access holes were punched using 19-gauge 
needles (McMaster-Carr). Plastic clamp holders were laser-cut with holes matching the 
inlets and outlets. Plastic holders and screws were applied to hold the PDMS device and 
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glass substrate together for protein coating. Assembled devices were taken out of the 
holders gently for experiment under microscope.  
4.3 T cells interact with immobilized pMHC under flow 
 Unlike static condition where cells have a long time interacting with the surface, 
the flow condition provides a chance to investigate the rapid contact scenario. We assessed 
the interaction between OT1 T cells and its ligands under flow condition by measuring 
velocity and adhering cell density. Flow channels were coated with ligands of OVA, Q4R7, 
Q4H7, G4, or VSV at a coating concentration of 25 µg/ml, and BSA blocking coating 
served as a negative control. Cell behavior was highly dependent on the shear rate: higher 
shear rate resulting in cell moving, while lower shear rate resulting in cell adhering. Hence, 
I applied wall shear rate of 25 s-1 and 15 s-1 for the measurement of velocities of the moving 
cells and density of the adherent cells respectively. Mean velocities of the individual 
moving cells near surface were measured for each coating conditions at the same wall shear 
rate (Figure 4-2a). Inserted figure indicated the number of moving T cells and adherent 
cells at this condition, which demonstrated the dominance of the moving cell numbers. 
Moving cells on OVA and Q4R7 surface had significant lower mean velocities than the 
rest conditions, suggesting interactions between the T cells and the surfaces. We also 
assessed the adherent cell density on surfaces under the low shear rate (Figure 4-2b) to 
further validate the cell-surface interactions. Three distinct groups were shown by the 
adherent cell density measurement: OVA and Q4R7 (high density), Q4H7 and G4 (medium 
density), and VSV and BSA (low density), which agreed with antigen affinity differences 




Figure 4-2 The observation of T cells interacting with immobilized OVA under 
flow. a) Velocity of the OT1 T cells moving on the pMHC surface (25 µg/ml) 
under a shear rate of 25 s-1. Inserted graph represented the number of moving T 
cells and adherent cells. Data are presented as mean ± se of 15-20 cells. 
Experiment was repeated 3 times with consistent results and the representative 
data are shown. b) Adherent cell density of OT1 T cells on each pMHC surface 
under a low shear rate of 15 s-1. Each dot indicated one experiment. *, **, *** 
and **** denote, p < 0.05, 0.01, 0.001 and 0.0001, respectively, by Student t-test. 
 
 To test whether the velocity reduction of cells on surfaces of OVA and Q4R7 was 
induced by the flow and channel difference, we also measured the velocities of cell above 
of surface (Figure 4-3). The data of the velocities of cells near surface (red) were replotted 
from Figure 4-2 a, while the velocities of the cells above surface were plotted as 
comparison (black). Among all surface conditions, the velocities of cells above surfaces 
showed no sign of significant difference, suggesting that any velocity difference of the cells 
near surface was due to the ligand-coated surfaces. Together with Figure 4-2, this suggested 




Figure 4-3 The velocity of T cells in the flow. A comparison of velocities above 
the surface (black) and near the surface (red). Velocities of the OT1 T cells 
moving above the surface, meaning no interaction to the surface, had no 
significant difference among the various pMHC coating. The velocity data of 
‘near surface’ T cells were the replotted from Figure 4-3. This confirming that 
the difference of moving velocities of near surface T cells on various pMHC 
surface was not due to the flow condition. Data are presented as mean ± se of 15-
20 cells. Experiment was repeated 3 times with consistent results and the 
representative data are shown. 
 
 To further assess the TCR-pMHC interaction by the behaviors of the cells, we 
analyzed the instantaneous instead of mean velocities of three groups of OT1 T cells with 
frame-by-frame tracking. Ten representative cells for each group were plotted in Figure 
4-4, cells classified as adhered on OVA surface, moving on OVA surface, and moving on 
BSA surface, respectively. The cells classified as adhered cells (Figure 4-4 a) had an 
instantaneous velocity largely at 0 µm/ s-1 with occasional movement. Cells on the BSA 
surface, as the opposite, were flowing without stop, at an average speed of 75 µm/ s-1 
(Figure 4-4 c). The variation of the velocity was caused by cell fluctuation and the 
72 
 
limitation of the spatial resolution. Velocity of OT1 cells moving on the OVA coated 
surface showed frequent stops and rapidly regained movement (Figure 4-4 b). This 
suggested the rapid rebinding and dissociation between TCR on OT1 cells and pMHC 







Figure 4-4 Instantaneous velocities of T cells on surface. Cell velocities analyzed 
for 10 representative cells for each condition: a) adherent T cells on OVA pMHC 
surface, b) moving T cells on OVA surface and c) moving T cells on BSA surface. 
Each panel represents one cell. Videos were taken under 10x magnification at 36 
f/s and analyzed frame by frame for 4 seconds for each cell. 
 
 Together with reduced mean velocities and increased adherent cell on pMHC 
surface, this study indicated that T cells can interact with surface-immobilized pMHC and 
form the rapid rebinding under flow condition. 
 
4.4 T cell LFA-1 activation stimulated by TCR-pMHC interaction 
75 
 
 T cell receptor interaction with pMHC upregulates integrin activation and function 
in immune synapse [62]. Thus, it is reasonable to assume that the TCR-pMHC interaction 
under flow would also generates the integrin LFA-1 activation. To test this, we coated the 
microfluidic channels pMHC OVA ligand with or without ICAM-1, which binds to 
activated LFA-1. Flow carried OT1 T cells were delivered (25 s-1) and cells were allowed 
interaction with the surfaces; the number of adherent cells was measured to assess the T 
cell interaction. The adherent T cells on OVA/ICAM-1 surface were significantly more 
than OVA alone surface (Figure 4-5), indicating an additional interaction to the ICAM-1. 
Channels coated with ICAM-1 alone served as a negative control, to confirm that the 
integrin LFA-1 was not activated in the beginning. Another non-specific pMHC, VSV 
[111], was also tested as a negative control, where channels were concurrently coated with 
VSV and ICAM-1. Very low level of adherent cells on VSV/ICAM-1 surface indicated 
that the interactions of T cells on OVA and OVA/ICAM-1 surface were specific. This study 
showed that interaction of T cell LFA-1 and ICAM-1 facilitated T cell adhesion under flow 
when pMHC OVA was at present, and this synergetic effect of TCR and integrin LFA-1 




Figure 4-5 Synergetic effect of TCR and integrin LFA-1 on T cell adhesion. 
Adherent cell fraction of OT1 T cells was calculated as ‘captured on surface / 
(captured on surface + collected in outlet)’ on each surface under a low shear 
rate of 25 s-1. Splenocyte sample includes other cell populations besides OT1 T 
cells. OVA and VSV coating concentrations were 25 µg/ml and ICAM-1 coating 
concentration was 20 µg/ml. Each dot indicated one experiment. *, **, *** and 
**** denote, p < 0.05, 0.01, 0.001 and 0.0001, respectively, by Student t-test. 
 
 Although we showed that TCR can interact with pMHC under flow condition and 
the interaction can recruit integrin-ICAM-1 interaction, it is still unclear whether 
engagement of the integrin LFA-1 on T cell surface must occur while TCR-pMHC interacts 
consistently as in an immune synapse. To temporally separate these two interactions, we 
applied our multi-zone device to address this question by functioning the stimulation zone 
with immobilized pMHC OVA (coating concentration 25 µg/ml) and reporting zone with 
ICAM-1 (coating concentration 20 µg/ml) (Figure 4-6 a). The length of the stimulation 
zone can be tuned to achieve various levels of stimulation dose and measure the adherent 
cell density at the reporting zone. For a given flow rate (shear rate = 15 s-1) and device 
dimension (1mm wide), a low adherent cell density was present at both no stimulation 
(BSA instead of OVA coated on the stimulation zone) and low stimulation dose (50 µm 
length) (Figure 4-6 b). Increase of adherent T cells on ICAM-1 reporting zone started when 
stimulation zone size increased to 200 µm and the adherent density kept rising at 400 µm 
and 800 µm. A hypothesized saturation of the adherent cell density was not observed for 
the given stimulation dose, indicating that a higher dosage may be required to achieve 
further stimulation. Positive controls were done by delivering cells onto a surface coated 
with a mixture of OVA and ICAM, or by pretreating the T cells with agonist Mn2+ (10 μM, 
15 min), which activated T cells to fully activated state. This suggested that the TCR-
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pMHC and LFA-1-ICAM-1 interactions can be spatially and so temporally separated, 
where the activation level of LFA-1 by TCR-pMHC interaction can be tuned by the 
stimulation zone size. 
 
 
Figure 4-6 Stimulation and probing activation can be separated in a dose-
dependent manner. a) Schematic of the multizone microfluidic channel for T cell 
stimulation and reporting. Highlighted pMHC zone is size-variable for different 
dose of stimulation. b) The activation of T cells was reported by their binding to 
reporting zone coated with ligand ICAM-1 (20 µg/ml coating concentration), 
after variable length of stimulation zone coated with 25 µg/ml pMHC OVA. 
Conventional flow chamber experiments with ICAM-1 and OVA co-presented 
were done as a positive control, as well as T cells incubated with Mn2+ for 10min. 
Dots indicated individual experiment. *, **, *** and **** denotes p < 0.05, 0.01, 




 It is known in literature [14, 97, 112] as well as demonstrated in chapter 3 that 
integrin LFA-1 activated by selectin interaction can support neutrophil rolling. Whether 
the integrin LFA-1 on T cell surface can support rolling and whether this can be enabled 
by TCR interaction all remained unclear. We next measured the velocity of pMHC 
stimulated T cells on ICAM-1 surface upon various stimulation doses to assess whether 
and how the velocity will be affected the activation dose. 
 Length of the stimulation zone was demonstrated to be an activation dose factor in 
Figure 4-6. It is intuitive to think that coating concentration could be another factor of 
activation dose. We varied the size of the stimulation zone with coating concentrations: 10 
µg/ml, 25 µg/ml, and plotted the velocity of T cells on ICAM-1 surface as a function of 
zone length for these two coating concentrations. Lower velocity indicates a stronger 
interaction between cell and surface molecules. As expected, the longer the stimulation 
zone was and the higher the coating concentration was, the slower the cells moved on the 




Figure 4-7 Activated OT1 T cell can roll on ICAM-1 in a mechano-dose- 
dependent manner. Velocity of T cells rolling on ICAM-1 (20 µg/ml) surfaces is 
plotted against the length of OVA zones. The stimulation zones with variable 
lengths were patterned with pMHC OVA concentrations of 10 µg/ml and 25 
µg/ml. T cells were perfused in the chambers with a wall shear rate of 25 s-1. 
Negative control of T cells on ICAM-1 surface without pre-stimulation was 
plotted at dose = 0 and positive control of T cells incubated with PMA/ionomycin 
for 10 min was plotted at right after dash line. Data are presented as mean ± sem 
of 15-20 cells. Experiment was repeated 3 times with consistent results. 
 
 It’s reasonable to speculate that zone length corelates to the total time a cell is 
possibly allowed for stimulation and the density of the surface molecules corelates to the 
‘frequency’ of a cell can interact to ligands. As ‘time x frequency’ is the total number of 
bonds a moving cell could possibly form, then the ‘coating concentration × zone length’ 
would also corelates to the total number of bonds that cells are allowed to bind. Thus, we 
plotted the rolling velocity of pMHC stimulated T cells on ICAM-1 surface against a 
combined stimulation dose factor ‘coating concentration × zone length’ (Figure 4-8 a). We 
observed the decrease of the velocity of T cells on ICAM-1 surface after a region of pMHC 
OVA, indicating a more activated state of the T cells. Interestingly, the velocity curves of 
all three OVA coating concentrations exhibited exponential decrease as the stimulation 
length increased. As they were plotted in the same combined ‘stimulation dose’ axis, these 
curves collapsed into one exponential decay curve. The negative control and the positive 
control were provided, by the velocities of the T cells on the ICAM-1 surface without 
stimulation and of the T cells pretreated with the PMA/ionomycin (which activates T cells 
to fully activated state), respectively. This supported our hypothesis of the effect of the two 
factors on T cell activation dose.  
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 We further assessed the effect of other pMHC ligands beside OVA. Q4R7 and 
Q4H7 are two alterations of OVA peptide and have lower affinity and potency to OT1 T 
cells [108]. We compared the velocity curve of the T cells on ICAM-1 after stimulation by 
these two pMHC with the fitted exponential decay curve of T cell velocity stimulated by 
the OVA (Equation 2) (Figure 4-8 b). Notwithstanding the fact that both Q4R7 and Q4H7 
stimulated T cells had lower velocities compared to the OVA stimulated cells, Q4R7 curve, 
had a similar fitted ‘steady state’ velocity as OVA fitted curve (Equation 3), but not Q4H7 
curve (Equation 4). This suggests that the velocity of T cells with a sufficient stimulation 
of Q4R7could potentially reach as low as OVA stimulated cells, while Q4H7 curve, 
conversely, could not reach the same rolling velocity even with abundant stimulation (fitted 
‘steady state’ velocity of ~ 55 µm/s-1 in Equation 4). This difference could be related to the 
pMHC binding kinetics for the fact that T cells bind to both OVA and Q4R7 with a catch-




Figure 4-8 Stimulation factors for pMHC activated T cell rolling on ICAM-1. a) 
Velocity of T cells rolling on ICAM-1 (20 µg/ml) surfaces is plotted vs. mechano-
dose (characterized by the length of stimulation zone times coating 
concentration). The stimulation zones with variable lengths were patterned with 
various pMHC OVA concentrations from 5 µg/ml to 25 µg/ml. T cells were 
perfused in the chambers with a wall shear rate of 25 s-1. Negative control of T 
cells on ICAM-1 surface without pre-stimulation was plotted at dose = 0 and 
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positive control of T cells incubated with PMA/ionomycin for 10 min was plotted 
at right after dash line. b) Rolling velocities of T cells stimulated by two weaker 
ligands were compared to OVA. One exponential fitting was done to collapsed 
OVA stimulation curves (black). Data are presented as mean ± sem of 15-20 
cells. Experiment was repeated 3 times with consistent results. 
 
𝑉𝑟𝑜𝑙𝑙𝑖𝑛𝑔 ⁡= 96.1 × 𝑒
−0.001826𝑥 + 18.2 
Equation 2 Velocity fitting of T cell activated by OVA 
 
𝑉𝑟𝑜𝑙𝑙𝑖𝑛𝑔 ⁡= 97.8 × 𝑒
−0.001323𝑥 + 17.7 
Equation 3 Velocity fitting of T cell activated by Q4R7 
 
𝑉𝑟𝑜𝑙𝑙𝑖𝑛𝑔 ⁡= 67.1 × 𝑒
−0.000864𝑥 + 58.9 
Equation 4 Velocity fitting of T cell activated by Q4H7 
 
 We first demonstrated the interaction of the T cells to the surface immobilized 
pMHCs by measuring the velocity and adherent cell on pMHC surfaces. Instantaneous 
velocity of the T cells of each behavior was provided to further confirm the rapid re-binding 
behavior of the T cells to the surface pMHC OVA. An activation of the T cells by the 
pMHCs, especially by OVA, were observed by measuring the increased adherent cells on 
ICAM-1 surface with OVA concurrently at present or separated in a multi-zone device. 
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We then assessed the velocity of the T cells on ICAM-1 surface in a pMHC stimulation 
does-dependent manner, by varying the length of stimulation zone and coating 
concentration. Different activated integrin behaviors were observed for various pMHCs by 
fitting velocity curves for the ultimate rolling velocity of various pMHC stimulations. 
Hence, we demonstrated that T cells interacts with surface pMHCs and this interaction 
activates integrin LFA-1 in a dose-dependent and pMHC-dependent manner. 
 
4.5 Calcium response of pMHC-stimulated T cells 
 Since calcium is an immediate downstream signal from TCR activation (within 
minutes) [113, 114], we further monitored the calcium flux of the T cells upon stimulation 
of the pMHCs to confirm the activation and investigate the different resulting behaviors by 
these pMHCs. Mouse OT1 T cells carrying calcium indicating dye (Fluo-4) were perfused 
into microfluidic channels coated with different pMHCs (25 µg/ml) for a distance of 800 
µm and monitored under epi-fluorescent microscope at a frame rate of 0.5 f/s and exposure 
time of 200 ms (Figure 4-9). Negative control of BSA blocked surface were provide for 
each condition as a reference. In general, the calcium flux magnitudes were as expected, 
strongest for OVA stimulated cells (Figure 4-9 a) and less for other alterations. Q4R7 
(Figure 4-9 b) was the closest to OVA among all alternations and G4 (weak pMHC, Figure 
4-9 d) and VSV (irrelevant pMHC, Figure 4-9 e) did not show a significant difference 
compared to BSA blocked surface. This suggests that the strength of TCR binding 




Figure 4-9 Calcium of pMHC-stimulated T cells indicates activation. Calcium 
flux of OT1 cells upon stimulation of pMHC a) OVA, b) Q4R7, c) Q4H7, d) G4, 
and e) VSV. BSA control (black) served as a reference for each condition. Data 
are presented as mean ± se of 15-20 cells. Experiment was repeated 3 times with 




 We next quantified the calcium flux data on the single cell bases to further 
investigate the effect of each pMHC by assessing the peak calcium intensity (Figure 4-10 
a), the area under curve (Figure 4-10 b) of each cell, and the response ratio of the calcium 
flux curve of the population (Figure 4-10 c). The general trend was as observed in calcium 
trace where OVA stimulated cell showed the strongest response and less for other 
alternation pMHCs. Additionally, this analysis illustrated the reason of the different 
activation level upon various pMHCs. The fact that cells upon OVA (or Q4R7) stimulation 
were more activated appeared in calcium response in two ways: 1) the stronger response, 
which was shown by the peak intensity value and the area under the curve, 2) the higher 




Figure 4-10 Quantitative analysis of calcium response upon various pMHC. T 
cell calcium flux data from Figure 4-9 were analyzed and plotted by a) calcium 
peak intensity and b) area under curve for single cells (each dot for one cell), and 
c) cell response ratio of all collection. For binomial distribution with event 
probabilities Pk, an estimate of the i-th event probability was set as the 
associated standard error s.e.m. *, **, *** and **** denotes p < 0.05, 0.01, 0.001 




 To understand the difference of the pMHC stimulated activation and non-specific 
activation of T cells, we assess the calcium flux of anti-CD3 antibody stimulated T cells 
with or without flow condition. Microfluidic channels were coated either with OVA (25 
µg/ml) or anti-CD3 antibody 2C11 (50 µg/ml). BSA blocked channels served as a negative 
control and reference. Surprisingly the 2C11 stimulated T cells, which usually serves as 
‘positive control’ for stimulation, had lower calcium flux level compared to OT1 T cells 
with flow condition. When we investigated the effect of the flow to triggering the calcium 
flux, OVA stimulated cell demonstrated a significant lower calcium flux without 
experiencing the flow compared to cells that experienced flow; yet the 2C11 stimulated 
cells did not shown a sign of magnitude difference whether they experienced flow before 
videoing. This coincided with the fact that binding of anti-CD3 antibody to T cells do not 
require force to trigger stimulation, thus providing additional evidence that force between 




Figure 4-11 Anti-CD3 stimulation triggers calcium with or without shear. 
Calcium fluxes of anti-CD3 antibody 2C11 and pMHC OVA stimulation were 
compared with or without flow condition. Data are presented as mean ± se of 15-
20 cells. Experiment was repeated 3 times with consistent results 
 
4.6 Conclusion 
 In this chapter, we demonstrated the activation conditions of T cells by specific 
pMHC and characterized the resulting rolling behavior of pMHC activated T cells. We first 
demonstrated the rapid rebinding of TCR-pMHC interaction by assessing the T cell moving 
velocity (for mean velocity and instantaneous velocity) and adherent cell density on 
immobilized pMHC surface under flow condition. T cell activation was then observed 
when cells were exposed to OVA and ICAM concurrently or spatially separated in multi-
zone device. A further investigation on the mechanical stimulation dose of the immobilized 
pMHCs was conducted by varying the coating concentration and length of stimulation zone. 
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By fitting the activation resulted rolling velocity of T cells on ICAM-1 surface, we 
demonstrated the ultimate velocity differences of various pMHCs. Together, we 
demonstrated that T cells interact with surface pMHCs and this interaction activates 
integrin LFA-1 in a dose-dependent, pMHC-dependent manner. Furthermore, calcium flux 
of T cells upon various pMHC stimulation revealed two reasons of the difference activation 
behavior: the response intensity level and percentage of the responder cells upon 
stimulation. We demonstrated the effect of the force between TCR-pMHC interaction by 
monitoring the calcium flux of T cells after experience a shear condition or always in a 
stationary condition. Compared to anti-CD3 antibody stimulation which does not require a 
force, T cell stimulated by OVA pMHC showed a higher calcium flux magnitude when 
experiencing shear. This suggests that the force is an integral part of TCR-pMHC 
engagement and signaling. This study adds more evidence to T cell triggering models with 
repeated bindings under force. Further studies on instantaneous signaling monitoring 





CHAPTER 5. ENGINEER MICROFLUIDIC PLATFORM TO 
SORT ANTIGEN-SPECIFIC T CELLS BASED ON ROLLING 
BEHAVIOR RESULTING FROM TCR-INTEGRIN CROSSTALK 
5.1 Introduction 
 T cells’ critical role in adaptive immunity makes it important to assess T cell 
phenotypes and functionality in both fundamental study [115, 116] (such as pathogenesis 
[117], tumor immunology [118] and autoimmunity [119]) and clinical practice [120-122] 
(such as vaccine targeting [123] and immunotherapy evaluation [121, 122]). Enumeration 
of certain antigen-specific T cells provides information of the patient’s healthy state as 
target T cell may proliferate as the cognate antigen grows [122]. Sorting and in vitro 
expansion of the certain target T cells have a great value in adaptive immune therapy as 
the effective T cells originate from the patient so cause no transplantation rejection 
response.  
 Antigen-specific T cells upon activation give rise to surface marker activation and 
subsequent effector functions such as cytokine production, cytotoxicity, differentiation and 
proliferation. Literature has shown that high adhesion affinity of TCR-pMHC binding is 
not for sure leading to T cell functioning [124]. Conventional approaches to identify and 
separate specific T cells are usually based on the adhesion strength of TCR-pMHC 
interaction, such as the use of multimerized pMHC with a fluorophore [125-128]. With the 
increase of the multimer number, sensitivity of the TCR recognition advances [127]. 
However, the nature of this approach results in the lack of the assessment of the T cell 
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functionality. Therefore, additional functional tests are required to validate the selected 
cells, such as activation biomarker expression and cytokine releasing. Recently researchers 
also applied the activation property of integrin LFA-1 to antigen-specific T cell selection 
in a flow cytometry-based assay by pre-incubating lymphocytes with peptide induced 
APCs for a time from minutes to hours [129]. This approach overcame the low affinity of 
TCR-pMHC by using a tetramerized ICAM-1-fluorochrome complexes to bind to activated 
integrin. However, optical based assays are limited in the number of antigen specificities 
aby the spectral overlap since physiological polyclonal T cells have a spectrum of 
responses. In addition, serial flow cytometry for detection is restricted by the sample size. 
Alternative to flow cytometry-based detection and sorting, microfluidics provides easy 
operation on cell manipulation and module compatibility, allows small sample size (~10µL 
to 10mL) and high throughput. 
 Microfluidic devices for cell sorting have been developed for various kinds of cell 
selection [130-133]. Majority of them are based on the physical properties of target cell 
such as size [134-136], density [137], stiffness [138] and electromagnet property [139]. 
Sorting approaches based on the cell adhesion have been developed in recent decades [140-
143], yet focused on the interactions of adhesive molecules [73] such as selectin [73] and 
integrin whose affinities (KD~0.1 µM to ~1 µM [144]) are much higher than signaling 
interactions like TCR-pMHC (KD ~1 µM to ~100 µM [145]). In this chapter, we developed 
a microfluidic platform that exploited the rolling properties of activated integrin (learned 
in CHAPTER 4) to facilitate T cell sorting. With the microfluidic power of precise protein 
patterning, cell manipulation, and module-compatibility, this platform consists of an 
activation zone for antigen-specific T cell activation and a sorting zone for responsive cell 
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selection. In the rolling sorting manner, the sample was fed into the device and collected 
without stop. This continuous sorting motion not only permits a potential high throughput 
but also simplifies the operation and allows extra microfluidic modules for immediate 
follow-up test. This system has potential advantages for follow-up target cell screening and 
function evaluation. 
 
5.2 Materials and methods 
5.2.1 Chemicals and proteins 
 RPMI 1640 1X w/ L-glutamine was from Corning Inc. (Corning NY). Mouse 
Erythrocyte Lysing Kit was from R&D systems (Minneapolis, MN). Molecular Grade 
Water was from Corning Inc. (Corning NY). Trypan Blue was from Sigma-Aldrich (St. 
Louis, MO). Mouse CD 8+ T cell enrichment kit was from STEMCELL Technology 
(Cambridge, MA). Recombinant mouse ICAM-1-Fc chimera was from BioLegend (San 
Diego, CA). EZ-Link™ NHS-PEG4-Biotin was from ThermoFisher Scientific (Waltham, 
MA). pMHCs (including OVA, Q4R7, Q4H7, G4, VSV) were from Emory NIH tetramer 
core facility (Atlanta, GA). 
 
5.2.2 Primary mouse T cell purification 
 The methods of mouse T cell purification from both OT1 transgenic mouse or 
wildtype B6 mouse are the same as in 4.2.2 (Primary mouse T cell purification). Briefly, 
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mouse spleen was collected for grinding and RBC lysis, followed by a negative purification 
of CD8 T cells with mouse CD8+ T cell enrichment kit (STEMCELL Technologies) with 
the EasySep protocol. 
5.2.3 Microfluidic device fabrication 
 Devices were molded from silicon wafers in polydimethylsiloxane (PDMS, 
Corning Sylgard 184, Midland, MI) by standard soft lithography. Stamping PDMS was 
made from a 25 μm-thick one-layer wafer fabricated in clean room (IEN, GT) with negative 
photoresist (SU8 2025, MicroChem). Sorting device was from a two-layer wafer with a 12 
μm-thick first layer and 13 μm-thick a second layer. The features on the transparency mask 
were transferred with UV photolithography. The surface of wafers was treated with 
tridecafluoro 1,1,2,2-tetrahydrooctyle-1-trichlorosilane vapor from United Chemical 
Technologies (Lewistown, PA) to facilitate release of PDMS from the mold. A mixture of 
PDMS (PDMS base and crosslinker in a 10:1 ratio for sorting device and 5:1 ratio for stamp) 
was poured on the mold and the whole preparation was left for curing for 2 h at 75 °C. The 
PDMS pieces were cut into shape and the device PDMS were punched using 19-gauge 
needles in inlets/outlets holes while stamp PDMS not. Instead stamp PDMS was treated 
with plasma before gently covered with protein solution, incubated in DI water sprayed 
petri-dishes for 1 hour at RT. Protein solution was then washed off with DI water and the 
stamp dried in air before transferring the protein to substrate surface. 
5.3 Design criteria 
 We have demonstrated in the Chapter 4 that T cells can be activated by the 
immobilized pMHC on surface and resulted in rolling on ICAM-1 surface. We also 
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demonstrated that activated LFA-1 on neutrophils can support lateral movement on 
inclined ICAM-1 surface. It is reasonable to suppose that rolling behavior of activated T 
cells on ICAM-1 surface could also lead to a lateral movement if the inclined ICAM-1 
stripes are patterned. Together, the study before provided a foundation to the feasibility of 
a platform that recruits the activated LFA-1 to amply the difference of antigen-specific T 
cells with non-specific cells, where TCR-pMHC interaction usually has a low affinity (KD 
~1 µM to ~100 µM) [145] compared to activated integrin (KD ~0.1 µM to ~1 µM) [144]. 
With the activation of the adhesive molecule LFA-1, T cells can more reliably adhere to 
target surface or slowly roll, but the specificity remained due to the activation specificity. 
Rolling neutrophils can move laterally on an pattern of inclined stripes of selectin [146] 
and ICAM-1 (CHAPTER 3). We hypothesized that same integrin LFA-1 can also support 
T cell rolling laterally upon activation. 
 Our platform design requirements are based on the application of distinguishing 
target cells from a polyclonal population. The target T cells in a mixed population should 
be specifically activated by its specific pMHC to a state where LFA-1 on the surface could 
roll on ICAM-1 surface. The activated T cells in the polyclonal population are then 
delivered to the next module, sorting zone, where interacting T cells roll on the ICAM-1 
surface. The requirement for the activation module is to fully activate the target cells, so a 
sufficient contact between cell and the pMHC needs to be guaranteed. The requirement for 
the sorting zone is to selectively distinguishing target cells from the rest T cells and a 
continuous separation of the cell populations is preferable.  
5.3.1 Scheme of the activation and sorting steps 
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 To achieve activation and selection of target T cells, we designed the two-module 
device as in Figure 5-1. Target T cells in a polyclonal population will be stimulated in the 
activation zone where an array of pillars is designed to increase the contact surface area 
and allow collisions between the T cells and the pillars to facilitate the TCR-pMHC 
interactions. After activation of the target T cells by the specific pMHC in activating zone, 
cells will be delivered to the sorting zone where the surface is functioned by inclined 
ICAM-1 stripes. Whereas the activated LFA-1 can interact with the ICAM-1 surface, at the 
edge of each stripe, T cells see two distinct areas: ICAM-1 surface and BSA-blocked 
surface. With an uneven interaction between cells and the surface, cells will be guided to 
move along the stripe edge, thanks to the flow shearing force along the channel. Hence, a 
lateral movement is achieved only in the interacting cells besides the longitudinal 
movement, while nontarget cells stay on the original side as the buffer is kept perfusing. 
At the end of the sorting zone, the target cells will be collected at the ‘collection outlet’ 




Figure 5-1 T cell sorting platform. a) Scheme of the platform. It consists of two 
parts: activation zone (left) coated with target pMHC and sorting zone (right) 
coated withICAM-1. Pillar array is designed to increase the contact surface area 
in activation zone inclined stripes is stamped to guide the target cells to move 
laterally in the sorting zone. Two inlets: cell inlet and buffer inlet. Two outlets: 
collection outlet and discard outlet. Two zones can be separated. b) real device 
design. The two zones wrapped up to fit the substrate size. The connection 
outlet/inlet was for the coating feasibility of the two part with two different 
protein patterns. 
 
5.3.2 Fabrication and experimental set-up 
 Device was molded from a two-layer master (silicon wafer, features fabricated with 
negative photoresist SU8), where pillars (h = 25 μm) in activation zone (Figure 5-1 a) were 
through the ceiling to the bottom while ridges (h = 13 μm) in sorting zone (Figure 5-1 
97 
 
b)were only on the ceiling. Matched stamp PDMS was used to pattern the inclined stripes 
of protein on the surface of the sorting zone. After protein ICAM-1 stamped on the surface 
of sorting region, markers were made to indicate the locations of the stamp pattern for the 
assembling of the device. Device PDMS was also treated with plasma before make contact 
with the glass substrate. Once contacted, activation zone was then coated with pMHC by 
perfusing the solution from the inlet to the ‘coating outlet’ without contamination to the 
sorting zone, and incubated for 1 hour. The blocking protein BSA was at last introduced to 
the whole device with the ‘coating outlet’ blocked. The ‘coating outlet’ was then blocked 
for the whole experiment. 
 Cell solution and buffer were delivered to the device by syringe pump, which was 
controlled by a MATLAB program (code in Appendix C). 
5.4 Activation region 
5.4.1 Pillar array design and simulation 
 Although a pillar array significantly increases contact area, a good design of the 
pillar array is required to have sufficient collision rates. The shape of the pillars was 
designed as diamond instead of traditional round to eliminate the cell sticking at the 
stagnation point. 5 designs based on the design criteria in literature [147] were fed into the 
COMSOL simulation. An example of the simulation result of the design #1 was shown 
with the red lines indicating streamlines (Figure 5-2 b). Streamlines were plotted 10 µm 
apart (on the order of a cell size) to illustrate all possible the location of the original cell. 
With every streamline illustrated has efficient collisions to the pillars (‘collision’ defined 
as a distance < 3 µm to a pillar), it means a cell could form sufficient collisions to the pillars 
98 
 
regardless of the starting position in the chamber. The criteria for sufficient collisions is 
defined as one collision of a cell to pillars in every 4 rows. By this criteria, three designs 
were selected for experimental test (Figure 5-2 a). 
 
Figure 5-2 Simulation identified the feasibility of the pillar array designs. a) 
illustration and parameters of the three designs; b) example of the simulation 
result on design #1. Red lines were streamline 10 µm apart. 
 
 We then tested the collision rate of the 3 designs (Table 5-1) whose collision rate 
was confirmed by the COMSOL simulation. Efficient collisions (at least 1 collision in 
every 4 rows) were achieved experimentally for all three, indicated by the distance of a cell 
centroid to pillar surface ≤ 3.5 µm (typical radius of mouse T cells is 3 µm). However, a 
design with bigger sizes yields bigger chamber size for activation, which limits the 
throughput of the sorting assay. Considering both the collision number over the entire 




Table 5-1 Experimental quantification of the collision rate revealed sufficient 
cell-surface contact. Collision rate of each design were presented of 15-20 cells 
from different starting locations.  
 
5.4.2 T cell activation characterization after activation region 
 To design the right size of the activation zone so to enable both activation and 
throughput, we assessed the time for T cells activation in microfluidics. A cell trap device 
[148] was applied study T cell activation by measuring the calcium flux trace of individual 
cells (Figure 5-3 a). Device was coated with specific pMHC and T cells were trapped in 
stationary condition to have contact with the surfaces. Calcium trace of individual single 
cells revealed a rise of calcium activation from 120 s to 240 s. Note that calcium is an 
upstream signal for LFA-1 activation and that this experiment only indicates the activation 
of T cells under stationary condition, while an activation under flow condition may be 
faster with shear force involved. However, this experiment provided an order of magnitude 
estimation of the activation of the T cells. 
 We then designed two activation zone chambers with the pillar array #1 and lengths 
that allows 2 min and 5 min travel of the T cells under a shear condition of 25 s-1. Activation 
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was defined as calcium intensity reach 2x of the mean of the original population. Only 
target cells were perfused into the chamber and the ratio of the activated cells of the outlet 
were plotted (Figure 5-3 b). While 2min-chamber already allowed an activation ratio of 
~70%, a 5min-chamber enabled majority (~85%) of the population activated.  
 
Figure 5-3 Cell activation by calcium flux was realized in activation chamber. a) 
calcium flux of the T cells in cell traps. Data are presented as the traces of 8 cells. 
Experiment was repeated 3 times with consistent results. b) ratio of activated 
cells for two activation zone designs indicated by a calcium intensity 2x of the 
original mean intensity. Data are presented as mean ± se of 4-5 experiments. 
Each dot indicates one experiment. 
 
 With assessment by both simulation and experimental test, we selected three 
designs for pillar array that enables sufficient collision rates. One of them was finally 
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chosen due to the collision per length efficiency. Cell trap calcium monitoring allowed a 
good estimation of the time course of T cell activation. A further validation was achieved 
by two length designs of the activation chamber. With these, an activation ratio of ~85% 
was achieved in the activation zone. 
 
5.5 Sorting region 
 The purpose of the sorting region to laterally move the activated T cells to the 
collection side and keep the non-interacting T cells in the original side (namely the discard 
side).  
5.5.1 Analysis of T cell rolling in inclined stripe area 
 To facilitate cell rolling laterally, several parameters are critical to link cell rolling 
ability to rolling trajectories and lateral displacement: coating concentration, angle of the 
inclined stripes and flow pattern. We first assessed the lateral movement of the pre-
activated T cells by measuring their trajectories on four different patterns of ICAM-1 
stripes: 5˚, 20˚, 45˚, 60˚ (Figure 5-4, a). Note that the ICAM-1 stripe patterns were stamped 
on the surface by manual alignment and a misalignment of ~3˚±1.5˚ was observed in 10 
times alignment measurements by imaging the off-alignment of target mask pattern and 
stamp position. Videos of the cells moving under a flow of 25 s-1 were taken for analysis 
of the individual cell trajectory by ImageJ. The angle of the individual trajectories in 
reference to the horizontal direction were also measured in ImageJ and quantified in Figure 
5-4 b. The green mark for 45˚ and 60˚ highlighted the feasibility of the use of these two 
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designs. With an angle degree of 2˚ over a sorting region with 3 cm, target cells are able to 
travel 1 mm laterally according to calculation. Considering the fact that cells are not always 
in contact with the surface and by some conditions move to the stream above surface, we 
designed a 5 cm long sorting region to enable lateral movement. 
 
 
Figure 5-4 Stripe inclination angles affected activated cell lateral movement. a) 
Four examples of cell trajectories for indicated stripes of patterned ICAM-1. 
Each line illustrated a single cell. scale bar: 10 µm. b) quantification of the 




5.5.2 Sorting platform design and experimental setting 
 In general, although a surface interaction could allow cell lateral movement, only a 
small fraction of cells interact with the surface, whereas the majority of the population 
remains in the flow stream. A shallower channel could force the cells to make contact with 
the surface; however largely increases additional clogging issues. We designed an array of 
ceiling ridges that are perpendicular to the flow direction to force cells making a contact 
with the surface and allowed enough space in between eliminating clogging issue (Figure 
5-5, a). Design parameters were listed in Figure 5-5 b. 
 
Figure 5-5 Ceiling ridge design in the sorting zone. a) cross-view illustration of 
the sorting zone. Blue stripes on the bottom indicated stamped ICAM-1 patterns 
and ridges on the ceiling were perpendicular to the flow direction. b) designed 
ridge parameters for difference cell sizes. 
 
 To determine the suitable coating concentration for cell lateral movement, we 
assessed a set of coating concentrations for stamping ICAM-1 surface. Pre-activated T cells 
were delivered into a 5cm-long channel where surface coated 45˚ ICAM-1 stripes. The 
lateral movement was quantified by the ratio of the cells ending up at the collect outlet out 
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of all (Figure 5-6). The lateral movement was observed to have a significant increase when 
the coating concentration was increased at 5 µg/ml and saturated from 10 µg/ml to 30 µg/ml. 
A decrease of the lateral movement occurred at 50 µg/ml, largely due to the depletion of 
the firm adhesion of the interactive cells on the surface, showed by a decrease of cell 
number at collection outlet but no sign of change at discard outlet. Thus, a range of 10 
µg/ml to 30 µg/ml coating concentration was selected for our sorting zone patterning. 
 
Figure 5-6 The concentration of ICAM-1 affected the lateral movement of target 
T cells. Ratio of lateral movement was depicted as collect/total (left). Flow left to 
right. Data are presented as mean ± se of 3 experiments. *, ** and *** denote p < 
0.05, 0.01 and 0.001 by Student t-test. 
 
5.5.3 Stop-flow pattern facilitate cell-surface interaction 
 The portion of cells missed the opportunity to interact with surface at the trade-off 
between increase cell contact and eliminating clogging (when channel is too shallow). Cells 
are uplifted away from the surface in a Poiseuille flow condition by the Segré–Silberberg 
effect [149, 150]. Without inducing the clogging issue, another way to increase contact is 
to diminish the Segré–Silberberg effect by settling cells on the surface without flow. 
However, cell settlement on the surface without flow may cause firm adhesion instead of 
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rolling, and a flow force is still necessary to cell lateral movement. Thus, we introduced 
the Stop-flow pattern to facilitate cell contact and resume flow once in contact (Figure 5-7). 
 We first assessed settlement of a cell when the flow stopped (Figure 5-7 a). The 
instantaneous velocity was measure frame by frame in 36 f/s video. The mean velocity of 
5 cells decreased when the flow stopped at t = 10 s and finally reach complete stop at t = 
20 s. A flow stops at least 10 s is preferable for the effect contact of a cell to the surface. 
We tested different Stop-flow patterns by measuring the lateral movement of the pre-
activated T cells. The ratio of the two side of the channel was plotted at the beginning of 
the channel (~ 1 for a even distribution from a common inlet) and at the end of the channel 
for different patterns (Figure 5-7, b, c). The patterns of a 15s stop with a 30s flow or 1min 
flow yielded best performance among all. We picked the 1min flow + 15s stop for the 




Figure 5-7 Stop-flow pattern allow better lateral movement. a) mean velocity of 
5 cells in a flow-stop condition. Flow stopped at t = 10s. b) illustration of ratio of 
the two side, for an even distribution of cells, ratio = 1 at the beginning. c) ratio 
of two side plotted for five stop-flow patterns listed on the bottom. Exact 
numbers of ratios were listed in the table below the graph. 
 
 In this section, we assessed the angle and coating concentration of the ICAM-1 
stripes on surface for cell lateral movement and employed ceiling ridges and Stop-flow 
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patterns to facilitate it. With these, we finalized the sorting region design and experimental 
setting. 
 
5.6 Sorting performance 
5.6.1 Mock sorting of target OT1 T cells from a mixture with B6 T cells 
 To demonstrate the sorting ability, we first assessed the lateral movement of the 
stimulated cells and non-stimulated cells in separate channels. The ratio of lateral 
movement was calculated as before, cells in collect outlet / total cells in both outlets (Figure 
5-8, a). Stimulated OT1 T cells were activated prior in the activation zone coated with 
pMHC, whereas non-stimulated T cells experienced the activation zone with BSA blocking 
coating. The sorting platform yielded a lateral movement of ~65% for stimulated cell 
population and very specific to the non-stimulated cell population (< 3%). This justified 
the ability of this platform to distinguish cells able to interact and roll on ICAM-1 surface 
from the non-interacting cell. 
 
Figure 5-8 Lateral movement of the stimulated cells and non-stimulated cells. a) 
illustration of the ratio of lateral movement as collect/total. Flow left to right. b) 
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lateral movement of the stimulated and non-stimulated OT1 T cells. Data are 
presented as mean ± se of 3 experiments. *, ** and *** denote p < 0.05, 0.01 and 
0.001 by Student t-test. 
 
 We assessed the sorting performance from a polyclonal population, by creating a 
mixture population of cells by target: non-target = 1:1. Buffer was delivered  to main a 
flow on the collect side (Figure 5-9 a), so the cells only stay on the discard side if no lateral 
movement occurred. T cells from wildtype spleen of B6 mouse (Figure 5-9, a, blue) were 
incubated with a cell membrane dye CellTrackerTM for image, while T cells from 
transgenic OT1 mouse (Figure 5-9, a, yellow) were incubated with same volume of PBS 
buffer. Ratio of potential sorted cells for each population was calculated as number of cells 
on the collect side out of two sides. We imaged the cell locations every 1 cm along the 
region to assess the distinguishing ability (Figure 5-9, b), so to estimate the most economic 
location for collection. Although the absolute value of the ratio of sorted cell differed from 




Figure 5-9 Primary OT1 T cells sorted from a mixture with non-target B6 T 
cells. a) illustration of the lateral movement and ratio of sorted cells for each 
population. b) Sorting performance of OT1 and B6 in a mixture on two separate 
days. Data are presented as mean ± se of 2-3 experiments. Experiment was 
repeated 3 times with consistent results. 
 
 We validated the antigen-specific T cell sorting in the platform by demonstrating 
the lateral movement of two populations in separate or mixed condition. OT1 T cells, which 
are specific to OVA pMHC [151], achieved 40%-60% sorting while non-specific B6 T 
cells remained in the original discard side (> 97%). Further purification is possible, for 
instance, by repeatedly application of the mixed population to the same sorting system, as 
many multi-stage separation processes do [152, 153]. 
 
5.6.2 Sort strong agonist activated T cells from weak agonist activated 
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 Lateral movement of interacting cells is a continuous spectrum outcome before 
collected as ‘collect’ or ‘discard’. Therefore, this lateral movement-based device allows 
more than distinguishing target and non-target cells. A potential assay of enumerating and 
sorting several groups of T cells with various interacting ability to the surface can be 
illustrated. We assessed this ability by distinguishing two population of ‘targeted’ cells but 
stimulated by two distinct pMHCs that activates the T cells differently as shown in Chapter 
4.  
 A mixture of OT1 T cells was created after inactive OT1 T cells experiencing strong 
pMHC OVA and weak pMHC G4 respectively in two activation zone (Figure 5-10, a). As 
before, a 1:1 ratio of mixture was delivered into sorting zone on the discard side when the 
buffer was perfused at the collect side (Figure 5-10, b). The ratio of the potential sorted 
cells for each population was calculated as number of cells on the collect side out of both 
sides. We imaged the cell locations every 1 cm along the region to assess the separation 
ability (Figure 5-10,c). To eliminate the potential effect of the cell tracker dye to the surface 
molecule interaction, dye application was flipped for the two populations in the experiment 
(dyed G4 stimulated cells on the left graph, OVA stimulated cells on the right). Significant 
differences started at the first monitoring spot (L = 1cm) and the differences persisted along 
the sorting region, which means a clear distinguishing between OVA stimulated T cells 




Figure 5-10 Distinguish OVA (strong ligand) stimulated and G4 (weak ligand) 
stimulated T cells. a) Two populations of the inactive OT1 T cells from same 
batch was activated in two activation chambers. b) The mixture of the two 
populations in sorting region. c) The ratio of potentially sorted cells for two 
populations along the channel. Data are presented as mean ± se of 2-3 
experiments. 
 
 We further assessed the capability of the platform separating T cells with activation 
levels more similar to each other (Figure 5-11). In fetal thymic organ culture, pMHC Q4R7 
was identified as the weakest negative selectors and Q4H7 as the strongest positive 
selectors [154], making Q4R7 and Q4H7 the closest selection ligands in affinity spectrum 
[111]. These two ligands were used in two separate activation chambers. Dye application 
was flipped for these two population in two separate experiment (dyed Q4H7 stimulated 
cells on the left graph, Q4R7 stimulated cells on the right). Started with a mixture of 1:1 
ratio, the final collected population yielded an enrichment of target cell fraction from 50% 
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to ~55% of the stronger pMHC stimulated cells. These two ligands of similar activation 
potency defined the separation resolution of the system. However, additional iterations of 
enrichment may increase the enrichment further.  
 
Figure 5-11 Assessment of the distinguishing capability by two populations 
stimulated by two pMHCs with close potency. The ratio of potentially sorted 
cells for two populations along the channel. Data are presented as mean ± se of 
2-3 experiments. 
 
 We validated our hypothesis of distinguishing cells with different levels of 
activation, namely interactive ability to the stripes. A clear difference between OVA 
stimulated and G4 stimulated OT1 T cells were demonstrated in the sorting platform, where 
OVA stimulated T cells were significantly enriched from the original population. A test of 
the close-potency ligands (Q4R7 and Q4H7) were also applied for device capability 
assessment. Though enrichment of the cells stimulated by the stronger ligand was not as 
obvious, a difference between the two populations persisted throughout repeats with or 





 In this chapter, I developed a platform for antigen-specific T cell sorting by 
activating target T cells in an antigen-coated chamber array through TCR-pMHC binding 
and drafting the activated interactive T cells moving laterally by integrin-ICAM-1 
interaction. The efficiency of the sorting was improved by the pillar array design of the 
activation zone and designs in sorting zone including stripe angels, ceiling ridges, and stop-
flow pattern. We validated this platform by mouse primary OT1 T cell sorting from non-
target cells and demonstrated the ability to distinguish strong ligand activated cells from 
weak ligand activated.  
 Further improvements are needed for better sensitivity and higher cell collection 
ratio. Iterative cycles of enrichment can be one of the options. Physiological cell types and 
whole blood performance need to be tested before broad applications. Nevertheless, with 
the high specificity of the sorting, this platform would allow selection of cells in interest 
for sequencing or follow-up studies on these cells. The ability for distinguishing cells with 
different activation levels may allow a potential application of ‘interactive cell 
chromatography’ where a polyclonal population can be disassembled in a spectrum 




CHAPTER 6. CONCLUSIONS AND FUTURE DIRECTIONS 
6.1 Summary 
 Cell adhesion through receptor-ligand interactions is an essential way for cells to 
sense and respond to the environment. Although extremely common in cellular processes, 
multi-receptor crosstalk lacks an efficient technique for profound study with precisely 
controlled ligand stimulation, detangling measurement of the effect by several receptor-
ligand interactions. In this thesis, two high-throughput platforms regarding cell multi-
receptor crosstalk were established: 1) multi-zone platform, which allowed the study of 
receptor crosstalk in a spatially and temporally separated way with precise control of 
stimulation; 2) cell sorting platform, which take advantage of the knowledge of T cell 
intermediate adhesion signatures learned on multi-zone device and applied it in a sorting 
device. 
 An auto-alignment protein patterning technique was first developed for sequential 
ligand presentation in a multi-zone device in CHAPTER 2. Contacting the ligands 
separated spatially detangled the adhesion measurement of the several pairs of receptor-
ligand interactions, but retained the triggering effect of one protein to another on cells. The 
species, the concentration and the zone length of surface-immobilized molecules can be 
well-controlled, so as to provide precise, tunable doses of mechano-stimulation to study 
cell multi-receptor adhesion and signaling cascades. Advanced parallel version of this 




 In CHAPTER 3, I exploited the multi-zone device on two biological systems, 
platelets and neutrophils. The characterization of the platelet integrin adhesion behavior 
and conformation upon various dose of mechano-stimulation contributed to the discovery 
of the integrin intermediate state. Furthermore, the subtle difference of diabetic platelets 
was amplified for detection in this device using only one-drop of whole blood sample, 
which is highly unlikely to achieve by current techniques with such limited sample. In 
addition, neutrophil integrin LFA-1 activation was assessed by separating the stimulation 
and behavior reporting. The activation requirement and the effect of two parameters were 
studied.  
 The same integrin expressed on neutrophil also exist on T cells. Studying the 
stimulation of LFA-1 by T cell receptor in cell moving condition could contribute to our 
understanding of T cell activation. CHAPTER 4 investigated the interaction of T cell 
receptor with its ligand pMHC and the resulting activation of integrin LFA-1 measured by 
the rolling behavior on ICAM-1 and activation of the cell measured by calcium flux. By 
controlling the density and length of the surface-immobilized ligands, I was able to 
characterize the stimulation dose-dependency of T cell activation. 
 The knowledge of pMHC-activated T cell rolling gained from CHAPTER 4 
contributed to the development of an antigen-specific T cell sorting platform in CHAPTER 
5. The platform consists of two parts: an activation zone for target T cell stimulation and a 
sorting zone coated with a pattern of integrin ligand ICAM-1 allowing activated T cells to 
move with an angle to the flow direction. I validated the platform with mouse primary OT1 
T cell sorting from non-target B6 T cells. Based on the activation response rather than 
direct receptor affinity, this platform successfully identified the functionally active target 
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cells. Considering its advantages including short time scale, continuous sorting manner, 
and module compatibility, this platform can certainly be implemented for enumeration and 
isolation of functional T cells in the future, provided that repeated sorting can be realized 
systematically. 
 
6.2 Further works 
 Hardware and fabrication processes can certainly be improved to make the 
platforms more user-friendly for broader applications. Advances of the systems I 
developed in this dissertation can be explored in the further to make them more powerful. 
Additional biological questions can then be investigated. 
 
6.2.1 Broader applications of the multi-zone device 
 Our device has demonstrated its ability of studying cooperative receptors; it is 
reasonable to speculate that it can also be used to study the antagonistic effect between 
receptors [155-157], such as the inhibitory effect of programmed cell death protein 1 (PD1) 
[158] and CTLA-4 to T cell receptor (TCR) [159], which has been known to play a critical 
role in tumour immunology [158], or even more complex systems involving multiple 
receptor species where both cooperative and antagonistic concurrently play a role [160]. 
This would largely extend our understanding of cell mechano-signaling, for instance 
understanding the acute inhibitory effect of antagonistic receptors to T cell should 




6.2.2 Coupling other techniques for multi-parameter analysis 
 Adherent cell density and translocation velocity are the two major readout of our 
current system; calcium flux can be applied to certain cells as well. However, more 
parameters of response can certainly be measured by incorporating other techniques [161, 
162]. For instance, DNA force probe [162] that reports the binding force between a receptor 
and a ligand can be patterned on the stimulation region to assess the requirement of 
stimulation force or on the reporting region for the measurement of cell receptor activation.  
 In quite a few biological processes such as inflammation, multiple types of cells are 
involved [163-165], which communicate with one another. Cells, instead of purified 
proteins, can be patterned on the multi-zone device surface, such as a layer of adhered 
endothelial cells, which will allow the study of direct cell-cell crosstalk. Future study can 
explore the platelet-leukocyte recruitment such that one step forward can be accomplished 
to the cellular mechanistic processes such as development of atherosclerotic lesions [166] 
and acute inflammation [165]. 
 
6.2.3 Improvement on sorting with mechanism study on cell rolling signature 
 Although Figure 4-8 (Page 81) showed the considerable difference of rolling 
velocities between Q4R7- and Q4H7- activated T cells, an enrichment limitation was 
demonstrated in Figure 5-11 (Page 112) between OT1 cells activated by these pMHCs. 
Even with a statistically significant difference of the lateral movement of the two 
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populations, the enrichment level within one round of sorting was imperfect. It remained a 
question of what are the parameters of the cell adhesion signatures that affects the lateral 
movement on inclined ligand stripes if rolling velocity was not enough for prediction. One 
can further investigate on the rolling properties that contributes to the effective lateral 
movement such that a clear sorting of polyclonal T cell spectrum can be realized for 
multiple outlet collections of single population. 
 
6.2.4 T cell sorting with unknown antigen 
 All the current approaches can only be applied to sort T cells to known and synthetic 
ligands. However, in numerous disease cases, we could not acquire the ligands before we 
determine the target molecule. Sorting of T cells targeting tumor cells without knowing or 
acquiring the ligands would have tremendous value in clinics. In this practice, tumors including 
the tumor cells and leukocytes can be broken down to make membrane micro-vesicles by 
ultracentrifuge. The micro-vesicles can then be delivered to the activation zone and seeded on 
the surface. Since the membrane contains the specific pMHC from the leukocytes trapped in 
the tumor, corresponding T cells have the chance to interact with the surface through the TCR-
pMHC interactions. Resolving the lipid seeding, noise discrimination and specificity 
enhancement, one can sort T cells targeting an unknown antigen and collect the sorted cells for 






Appendix A. Multi-zone device assembling for identifying zone location 
 
 The location of the cell relative to the starting point of the interaction is an 
estimation of the cell experiencing time. Transient or changing state exist in a lot of cell 
activation process. In these applications, the zone locations on the substrate need to be 
identified for accurate estimation of activation changing over time.  
 To provide the accurate zone location, especially the boundary of the stimulation 
zone and reporting zone, markers on the channel device PDMS was designed for 




A 1. Process to align markers on channel device to the zone location. Stamp and 
contacted substrate glass were placed and taped onto a mask with markers. 
Took off the stamp before put channel device onto the glass according to the 
markers on the mask. Held the device and delivered coating solution with the 
clamp. 
 
 A preliminary study of platelet activation changing over time was investigated on 
multi-zone device. After activation by VWF-A1, platelets entered the zone of Fg or FN. 
Instead of measuring the velocity or adherent density of the cells, we tracked the cells along 
the reporting zone to observe their velocity changes on the Fg (A 2 a) or FN (A 2 b) surface. 
Comparison of the velocities on reporting surface across the time indicating a more 
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activated state through time when intermediate-state platelet interacting with FN and Fg 
(A 2 c). 
 
A 2. Activation maturation of platelets on reporting zone. Individual platelet 
velocities on Fg (a) or FN (b) were plotted after activation by VWF-A1. c) A 
summary of the velocities was plotted, and velocities were compared across the 
time of platelets on reporting zone. Dots indicated individual experiment. *, **, 
*** and **** denotes p < 0.05, 0.01, 0.001 and 0.0001, respectively, by One-way 
ANOVA. 
 
Appendix B. Antibody Kim127 production and purification 
 The key conformation antibody to report intermediate state of integrin LFA-1 was 
produced and purified from hybridoma B cells. 
B.1. Hybridoma culture 
 Hybridoma B lymphocyte (mouse) was purchased and cultured for antibody 
KIM127 production. Initial recovery and cell expansion culture were conducted as standard 
cell culture procedures. After expansion, cells were gradually transferred to a protein-free 
media (Thermo Fisher Scientific) so that extraction of antibody would not be affected by 
the albumin in culture media. The adaptation of the protein-free environment took 4 steps: 
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0% protein-free media (100% normal RPMI 1640 media), 50% protein-free media, 80% 
protein-free media, and 100% protein-free media. After the adaption, supernatant media 
was then collected after 2-3 days of culture and ready for purification. 
 
B.2. Antibody purification 
 We first ran gel electrophoresis to validate the existence of the antibody KIM127 
in cell media (A 3). The structure of heavy chains and light chains in the antibody was 
verified by the reduced sample. Heavy chains of ~50 kd and light chains of ~20kd creates 
the dimer antibody ~150kd. 
 
A 3. Existence of the antibody KIM127 by gel electrophoresis. Three difference 
concentrated media supernatant was compared to the calibration. Left was the 
original supernatant, protein detected at ~150KD (supposed to be the antibody 
KIM127). right was reduced (break the disulfide), heavy chain and light chain 
can be observed. 
 
 Column G was used for antibody purification. Gel electrophoresis showed 




A 4. Extraction and purification of antibody KIM127. Protein was shown to exist 
in original supernatant and elution solution, but not in flow through or wash 
solution.  
 
Appendix C. Cell sorting system 
C.1. Components 
 A microscope to monitor and image. 
 A two-way syringe pump to deliver cell solution and buffer. 
 A computer to record video and control syringe pump. Computer and syringe pump 
were connected with a cable: network cable to PC and to "to computer" network port on 
pump. 




C.2. Code for stop-flow pattern 
 
 To create a stop-flow pattern, MATLAB code was modified for syringe pump 
controlling. The GUI file was created before and I modified the following part to control 
the time of running and pause. 
 
% --- Executes on button press in togglebutton13. 
function togglebutton13_Callback(hObject, eventdata, handles) 
% hObject    handle to togglebutton13 (see GCBO) 
% eventdata  reserved - to be defined in a future version of MATLAB 
% handles    structure with handles and user data (see GUIDATA) 
  
% Hint: get(hObject,'Value') returns toggle state of togglebutton13 
if handles.pumpvalidity(1) == 1    
num1 = 5; 




for i = 1:10 %cycle number to end 
dstart = tic; 





%run ptime and stop 









%pause another ptime 









     
   fwrite(handles.pSer,['1 STP' 13 10]); 
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